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ABSTRACT OF THE DISSERTATION 
 
Characterizing nonmodel microorganisms and reconstructing catabolic pathways for bio-
productions 
by 
Whitney Hollinshead 
Doctor of Philosophy in Energy, Environmental, and Chemical Engineering 
Washington University in St. Louis, 2016 
 
In the 1970s, spikes in oil prices sparked early interests into first-generation biofuels (i.e., 
the production of ethanol from corn). Four decades later, biofuel manufacturing has under-
performed as developed industrial strains suffer from poor performance and the high costs of 
feedstocks.  While the advancement in molecular biology has greatly benefited our field, 
industrial microbial hosts still cannot overcome the obstacles to become profitable bio-
production. One approach may be to study non-model organisms and employ their metabolic 
features towards an improved bio-production pipeline.  Here, this thesis aims to develop 
13
C-
metabolism analysis tools to characterize novel organisms and re-program cell metabolism using 
novel pathways for better biosynthesis.  
First, the thesis introduces fast 
13
C-metabolism analysis via parallel 
13
C-fingerprinting for 
pathway delineation as well as quantitative 
13
C-MFA using WUflux or other published software.   
Second, genome-to-phenome mapping was performed for an oil-rich and inhibitor-tolerant 
bacterium, Rhodococcus opacus PD630, to improve conversion of lignocellulose to biodiesel. 
One major discovery was the simultaneous use of the Entner-Doudoroff pathway (EDP) and 
gluconeogenesis for co-utilizing phenolic compounds and sugar without catabolite repression.  
 
xi 
 
Third, we analyzed the fastest-growing cyanobacterial strain isolated, Synechococcus 
elongatus UTEX 2973, through isotopically non-stationary 
13
C-Metabolic Flux Analysis. The 
flux results indicated that Synechococcus 2973 has efficient catabolic pathways with minimal 
carbon loss after CO2 fixation as compared to the model cyanobacterial chassis Synechocystis 
6803. These results inspired the engineering of Synechocystis 6803 for improved carbon fixation 
efficiency by overexpression of EDP and knockout of CO2 re-generating pathways.  
Fourth, the thermodynamically favorable EDP pathway was also engineered in E. coli to 
improve carbon utilization and biomass growth. However, the EDP engineering only re-directed 
a small portion of its flux, but through a downregulation of Embden-Meyerhof-Parnas Pathway 
via pfkA knockout the flux was significantly elevated. Also, the ΔpfkA mutants showed co-
utilization of acetate and xylose without glucose catabolic repression. Furthermore, 
13
C-pulse 
experiments suggested a possible presence of glycolysisosome, in which sugar phosphate 
metabolites can be passed between enzymes without mixing with the bulk phase. Finally, this 
PhD thesis discusses future directions of metabolic engineering and 
13
C-metabolism analysis to 
achieve commercial success with bio-based productions. 
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1 Chapter One: Introduction  
This chapter was partially adapted from the following publication (full version included in 
appendix): 
Hollinshead, W.D., He, L., & Tang, Y.J. Biofuel production: an odyssey from metabolic 
engineering to fermentation scale-up. Frontiers in Microbiology  5 (2014). 
Abstract 
Metabolic engineering has developed microbial cell factories that can convert renewable 
carbon sources into biofuels. However, there are major roadblocks preventing economical 
biofuel/bio-based production among them are low profit margins, limitations imposed by 
metabolic burden, and low stability of microbial hosts. These challenges have prompted 
metabolic engineers to find and develop new microbial hosts with better productivity, cost 
efficiency and improved stability at large-scale bioproductions. With this renewed interest in 
non-model microbial hosts, characterization of their metabolism through 
13
C-analysis is a 
necessity to evaluate their potential and suggest rational engineering strategies. In this chapter, 
the background, motivation, and chosen approaches used throughout the thesis are discussed.  
 
 
Figure 1.1 Feedstocks and products of biofuel producers 
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1.1 Challenges facing Biofuel Industry 
Extensive research has been performed on the microbial production of biofuels using 
renewable feedstocks (Fig. 1). Ethanol fermentation by yeast is by far the most developed biofuel 
process, but low combustion energy and high purification costs prevent the wide use of ethanol 
as an economical fuel. Thereby, researchers have engineered microbes to produce new advanced 
fuels. Advanced biofuel examples include higher alcohols via the keto-acid and the Ehrlich 
pathway (Atsumi et al. 2008), terpene-based fuels (e.g., isopentenol) from the mevalonate 
pathway (Withers et al. 2007), fatty acid ethyl esters (Kalscheuer et al. 2006; Steen et al. 2010) 
and alkanes from fatty acid biosynthesis pathways (Choi and Lee 2013). Despite the 
development of these diverse biofuel producers, it is still challenging to commercialize biofuel 
processes due to the poor microbial productivity in large bioreactors and the low profit margins 
of biofuels (LaMonica 2014; Zhang 2009). The main carbon source for biofuel production has 
typically been obtained from food crops. However, concerns have been raised on linking biofuel 
production with food sources. In summary, current molecular biology tools can efficiently alter 
enzyme levels to redirect carbon fluxes toward biofuel production, but low product yield and 
titer in large bioreactors prevent the fulfillment of cheap biofuels. 
1.1.1 Carbon and Energy Metabolism Trade-off 
Although current molecular biology tools can effectively alter enzyme levels to redirect 
carbon fluxes toward biofuel production, low product yield and titer in large bioreactors have 
prevented the fulfillment of cheap biofuels. The high demand of energy and reducing equivalents 
during biofuel synthesis is an important obstacle. First, polymerization of protein and DNA/RNA 
requires large amounts of ATP (39.1 mmol). Production of biomass, enzymes for biofuel 
synthesis, plasmids/mRNA, or synthetic scaffolds consumes not only carbon building blocks, but 
3 
 
also energy molecules. Second, large amounts of ATP need to be consumed to support cell 
maintenance processes including energy spilling, microbial motility, cell component repair, and 
re-synthesis of macromolecules (Hoehler and Jorgensen 2013).  Third, the synthesis of biofuel 
molecules needs ATP and NAD(P)H. For example, fatty acid production requires 7 ATP and 14 
NADPH to convert acetyl-CoA molecules into one fatty acid (Palmitate, C16:0). Use of carbon 
oxidation pathways (such as TCA cycle and oxidative pentose phosphate pathway), and 
transhydrogenase reactions is necessary to generate sufficient NADPH and ATP for fatty acid 
synthesis(He et al. 2014; Varman et al. 2014).  
In addition to the high ATP demand imposed by the biofuel synthesis pathways, 
metabolic flux analysis studies have revealed that the overexpression of biosynthesis pathways 
significantly increases ATP maintenance expenditure(Ow et al. 2009), and the metabolic burden 
in engineered microbial hosts further causes poor respiration efficiency (e.g., P/O ratio = 
1.3)(Sauer and Bailey 1999; Varma and Palsson 1994). Extensive genetic modifications often 
increase metabolic burdens on the host and thus further interfere with cell growth and product 
synthesis (Colletti et al. 2011; Poust et al. 2014). For example, high copy number plasmids or 
strong promoter can place a heavy burden on the cell’s growth and negatively affect productivity 
(Carrier et al. 1998; Jones et al. 2000). If the hosts suffer from severe ATP limitations, efforts to 
reduce carbon losses or to increase carbon availability to biofuel synthesis will be futile. In this 
case, the metabolic bottleneck may shift from carbon limitation to energy limitation (insufficient 
energy molecules to power biofuel synthesis). Many metabolic engineering approaches to 
improve carbon efficiency can be effective in redirecting carbon fluxes to biofuel in low 
productivity strains (yield far below theoretical value), but these strategies may not raise product 
yields close to stoichiometric predictions if the engineered metabolism is unable to satisfy the 
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overall ATP and NAD(P)H requirements by the microbial hosts. Thereby, the priorities toward 
high carbon yield and energy efficiency have to be well understood and carefully balanced 
during strain development of biofuel producers.  
1.1.2 Low Profit Margins of Biofuel 
Even once strains are able to balance their energy and carbon metabolism to reach their 
theoretical yields with high productivity, they must then contend with reducing their production 
costs to be more competitive with petroleum fuels. Currently, biofuels receive subsidies from the 
government to offset their costs of production (Hill et al. 2006) but with changing political 
environments, that may not always be available. One of the approaches as discussed earlier is the 
shifted focus from ethanol to advanced biofuels such as biodiesel and terpenoid compounds that 
provide higher energy yields and better environmental benefits than ethanol production (Atsumi 
et al. 2008; Fischer et al. 2008; Shen and Liao 2008). In addition, many research labs and 
companies have worked to integrate lignocellulose, a potentially cheap feedstock, into biofuel 
production to lower costs, but utilizing lignocellulose brings many complications (Keasling 
2010; Kim et al. 2010).     
Lignocellulose consists of cellulose, hemicellulose, and lignin polymers which after 
undergoing a degradation step will release 6-carbon sugars (e.g., glucose), 5-carbon sugars (e.g., 
mannose, galactose, arabinose, and xylose), and toxic aromatics (e.g., phenolics)(Kim et al. 
2010).   Using this energy-abundant feedstock with current industrial microbial hosts such as 
E.coli and Saccharomyces cerevisiae would require additional engineering or evolution in 
addition to the engineering for biofuel production. First, the microbial hosts need to be able to 
utilize all of the available carbon sources and for better efficiency be able to utilize them 
simultaneously. For example, Saccharomyces cerevisiae cannot natively utilize xylose, and thus 
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has had heterologous xylose catabolic pathways introduced (Zhou et al. 2012).  E.coli has native 
xylose degradation pathways, but experiences glucose catabolite repression which restricts 
xylose consumption until glucose has been depleted. In fed-batch and continuous cultivations, 
this causes xylose accumulation and poor biosynthesis efficiency. It is ideal that both carbon 
sources be utilized simultaneously, thus increasing the productivity and efficiency of the 
bioprocess(Kim et al. 2010).  Most studies have needed to disrupt the primary glucose transport 
system (PTS), and/or over-express the xylose transporters to force glucose and xylose co-
utilization (Chiang et al. 2013; Jung et al. 2015; Lu et al. 2016; Su et al. 2015).  Lastly, the 
biofuel production from engineered microbial hosts is further hampered by the generated toxic 
phenolic and other inhibitory compounds released after lignocellulose degradation. They have 
been found to reduce growth and product yield (Ezeji et al. 2007). In summary, to widen the 
potential profit margin of bio-based productions, in particular for biofuel production, we need 
microbial hosts that can efficiently utilize cheaper feedstocks and produce more advanced 
biofuels. 
1.2 Different microbial platform to make bio-based productions feasible 
1.2.1 Cyanobacteria 
To overcome energy limitation and high feedstock costs, cyanobacteria are an attractive 
microbial platform for the production of high energy biofuels. Cyanobacterial species can 
survive in diverse nutrient and light environments. Cyanobacteria contain two photosystems 
(PSII and PSI), which forms a linear and a cyclic electron flow to produce ATP and NADPH for 
biomass growth and chemical biosynthesis. Under light limiting or impaired phototrophic 
conditions, some cyanobacteria may obtain electrons from organic carbons via oxidative pentose 
phosphate pathway and the TCA cycle. Some cyanobacteria strains can be integrated with 
wastewater treatment to become diverse photo-biorefineries for the productions of chemicals and 
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biofuels. In general, light harvesting cyanobacterial chassis offers a promising approach for 
designing cost-effective biorefinery. Recent research studies have successfully engineered model 
strains such as Synechocystis 6803 and Synechococcus elongatus  PCC 7942 and 7002 for 
biofuels such as isopropanol (Kusakabe et al. 2013), butanol (Lan and Liao 2012), and alkanes 
(Lindberg et al. 2010). However, the advancement of green cell factories for mass production of 
biofuels still has inherent obstacles. First, current model cyanobacteria still have low 
productivities due to slower growth and lower cell density than heterotrophs. Second, there is 
lack of understanding of cell metabolism in responses to genetic engineering strategies. Lastly, in 
photo-biorefinery systems, CO2 mass transfer and light penetration limitations create 
heterogeneous growth conditions and micro-environmental fluctuations that lead to non-optimal 
conditions for photosynthesis. A novel ‘green’ E. coli, Synechoccocus UTEX 2973, has been 
recently isolated and is capable of reaching the highest doubling times reported in 
cyanobacteria(~1.9 hrs), a rate similar to Saccharomyces cerevisiae(Yu et al. 2015).  This 
cyanobacterium removes some of the barriers in cyanobacteria bioproductions and holds possible 
clues to optimize cyanobacterial metabolisms for better growth.  Fluxomic approaches to 
rigorously identify these possible influential factors may present rational metabolic engineering 
strategies to enhance the metabolism of slow-growing model cyanobacterium, Synechocystis 
PCC 6803 for more effective autotrophic and photomixotrophic growth and biosynthesis rates.  
1.2.2 Non-model (Heterotrophic) organisms 
Current industrial strains can be engineered to improve their conversion of lignocellulose 
to biofuel, but many less-studied organisms naturally have beneficial traits for this conversion. 
They may have higher tolerance to aromatics, better carbon co-utilization, and higher flux 
towards biofuel synthesis pathways (Alper and Stephanopoulos 2009) .  Rhodococcus opacus 
PD630 is one of the most promising non-model microbes with its high TAG accumulation (up to 
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76% of CDW on gluconate)(Alvarez et al. 1996) and tolerance to lignin-derived aromatics 
(phenol) (Yoneda et al. 2016). The strain cannot, however, natively metabolize the other sugars 
of lignocellulose: xylose and arabinose but these pathways have been successfully engineered in 
the strain (Kurosawa et al. 2015; Kurosawa et al. 2013; Xiong et al. 2012).   
As novel organisms are being increasingly isolated and engineered, high-throughput 
systems biology techniques should be applied to characterize these strains and further our 
understanding of how these strains have evolved to develop these desired features. This is 
beneficial to not only the study of these organisms but can be translated into novel strategies to 
reprogram model organisms such as E. coli.    
1.3  13C-Metabolism Analysis 
Systems biology is used for characterization of microbes and provides guidelines for rational 
metabolic engineering. It can be broken into its “Omics” (genomics, transcriptomics, proteomics, 
and metabolomics) approaches, which can identify useful mutations, discover gene regulations, 
enzyme functions, and measure the metabolite pools in response to environmental fluctuations 
(Atsumi et al. 2010; Pham et al. 2006; Redding-Johanson et al. 2011). Although genome-wide 
analyses and computational modeling have provided knowledge for the metabolic engineering of 
microbial hosts (Park et al. 2008), it is not straightforward to correlate “omics” to actual enzyme 
functions due to complex post-transcriptional regulations (such as allosteric regulation) 
(Chubukov et al. 2013). For example, increases in mRNA levels may not lead to a corresponding 
increase in protein levels, while enzyme levels can remain constant despite frequent changes in 
carbon fluxes (Gygi et al. 1999). In addition, the existence of isoenzymes and poor enzyme 
specificity contribute to high metabolome diversity and lead to difficulties in metabolomic 
studies (Schwab 2003). To overcome such problems, 
13
C-MFA (metabolic flux analysis) is used 
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to directly measure enzymatic reaction rates. Thereby, metabolic flux analysis tools are required 
to provide the most straightforward information on the phenotype. Metabolic flux analysis 
determines the turnover rates of a large number of metabolic reactions that participate in the 
conversion of carbon sources into biomass building blocks and bio-products in the central 
metabolic network. They represent the functional output of the cellular processes responding to 
internal or external stimuli. Metabolic fluxes can be studied with Flux Balance Analysis (FBA). 
FBA model solutions are based on the stoichiometry of the metabolic reactions in addition to the 
measurement of inflow (e.g., substrate uptake) and outflow fluxes (biomass growth and product 
synthesis) under a steady state assumption (Eqn 1.1). In addition, a series of physical, chemical, 
and biological characteristics (e.g., enzymatic capacity) can constrain the feasible fluxes for a 
given physiological condition. The number of constraints in an FBA model is smaller than the 
number of reactions in the metabolic network. The model is then underdetermined, and it is 
necessary to postulate an objective function (e.g., growth rate maximization) to calculate a set of 
predicted fluxes.  
min max ,min ,max
max ( )
subject to 0
;
i
m m m
f v
S v
v v v v v v

 
   
                               Eqn. 1.1 
where v represents the overall flux values constrained by vmin and vmax, vm are measured fluxes 
(inflow and outflow) with same up-bound and low-bound. vk is unknown f(vi)  representing the 
objective function of a set of vi, and S is the coefficient matrix. A number of strategies are 
proposed to improve FBA predictions for cell metabolisms, including incorporation of 
thermodynamic principles into FBA (Boghigian et al. 2010), uses of proper objective functions 
(e.g., maximizing the biomass) (Schuetz et al. 2007); bi-level optimization approach to describe 
9 
 
“non-optimal” metabolism (e.g., trade-off between biomass and product yields) (Burgard et al. 
2003); minimization of metabolic adjustment to solve mutant strain fluxes (Boghigian et al. 
2010). However, the most rigorous flux analysis combines flux stoichiometry-based balance with 
13
C isotopic tracing, i.e., 
13
C-MFA. 
13
C-experiments consist of feeding the cell culture with a 
defined 
13
C-substrate to fingerprint downstream metabolites with isotopomers. The patterns of 
isotopic enrichment in metabolites once 
13
C distributes throughout the metabolic network can 
help decipher flux distributions in the cell metabolism (Tang et al. 2009c). The isotopomer 
information allows fluxes in branching (e.g., the pentose phosphate pathway versus glycolysis) 
and circular (e.g., TCA cycle) pathways to be determined.  
13
C-Metabolic Flux uses the 
stoichiometric model to generate possible fluxes, using computational non-linear least-squares 
regression algorithms to minimize the difference between the subsequently generated mass 
isotopomer distributions(MDVs) of proteinogenic amino acids with the experimental results 
(Eqn 1.2).  
Minimize ε = (MDVmeas - MDVcalc)
2
       Eqn. 1.2 
Subject to S • v = 0   
13
C-MFA requires careful planning of isotopomer labeling experiments and computational 
modeling of ordinary differential equations. Two core techniques are used for metabolic flux 
analysis: 1) steady state 
13
C-MFA discussed earlier and 2) isotopically non-stationary 
13
C-MFA 
which uses labeling kinetics of free metabolites measured using advanced analytical instruments 
(such as LC-MS). The mathematical statements can be described as follows (Nöh et al. 2007; 
Young et al. 2011): 
Minimize ε = (MDVmeas - MDVcalc)
2
    Eqn. 1.3 
Subject to S • v = 0 
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MDVcalc=MIDV-MDV • I      Eqn. 1.5 
vgrowth= μ Y       Eqn. 1.6 
 
 
where MDVcalc and MDVmeas are the calculated and measured mass distribution vectors of 
intermediates, respectively; S is the reaction stoichiometry matrix, and v is the vector of all 
fluxes; C denotes a diagonal matrix of intracellular metabolite concentrations; I is the overall 
isotopomer distribution vector; Pj is a matrix describing the transitions from reactant to product 
isotopomers (isotopomer formation by monomolecular reactions); Qj is a matrix describing the 
transitions from reactant to product isotopomers (isotopomer formation by bimolecular 
reactions); the sum of the product of Pinp Iinp and vinp (the third term in the equation 2) describes 
extracellular reactants (input) to their intracellular counterparts; MIDV–MDV is a matrix that 
converts the isotopomer distribution vector I into MDVcalc; vgrowth is the flux to biomass; vsubstrate 
is the carbon substrate utilization normalized to 100 units (μmol h-1); μ is the specific growth rate 
(h
−1
); Y is the biomass yield per 100 mole carbon of substrate utilized by the bacteria.   
 
13
C-metabolism analysis is an important tool that can reveal: 1) novel pathways useful for 
biosynthesis; 2) rate-limiting factors controlling cell performance; 3) carbon and energy fluxes 
through a complex metabolic network.   
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2 Chapter Two: Metabolic Flux Analysis through 
13
C-labeling  
This chapter includes some work from the following two publications: 
Ruan, Z., Hollinshead, W., Isaguirre, C., Tang, Y.J., Liao, W., & Liu, Y. Effect of inhibitory 
compounds in lignocellulosic hydrolysates on Mortierella isabellina growth and carbon 
utilization. Bioresource Technology. 2015. 183, 18-24. (I contributed to 
13
C-labeling Analysis)  
 
Hollinshead, W.D., & Tang, Y.J. He, L., Metabolic Flux Analysis through 13C-labeling. 
Methods in Molecular Biology: Microbial Metabolic Engineering. Springer. [Manuscript in 
Preparation]. (I have contributed with the drafting of the protocol) 
 
Abstract 
13
C-assisted metabolism analysis provides rigorous calculations of the intracellular reaction rates 
(i.e., fluxes) within the central metabolism of microbial hosts. This mapping of the intracellular 
network within microbes has proven to be essential for understanding the cell physiology.  The 
approach can identify central metabolic nodes, probe the rigidity of a metabolic network and 
reveal hidden pathways. Here we present the methodology of using stable isotopic analogues of 
carbon substrates for both qualitative and quantitative (
13
C-Metabolic Flux Analysis; 
13
C-MFA) 
metabolism analysis.  
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2.1 Introduction  
There has been a long history of utilizing isotopic tracers to resolve important questions on 
cell physiology from DNA synthesis (Meselson and Stahl 1958) to metabolic analysis (He et al. 
2014), which now has become the essential backbone of fluxomics, the study of the in vivo 
reaction rates. This ‘omics’ toolbox can be applied to many microbes for deciphering the 
topology and functionality of their metabolic network. These insights directly link the internal 
network of the microbe with its resulting phenotype. In addition, fluxomics can be integrated 
with other omics approaches such as genomics and transcriptomics to offer a bottom-up 
approach that can exposes internal regulations within the cell.  
13
C-metabolism analysis can be 
used in a either qualitative or quantitative manner (see Figure 2.1). While 
13
C Metabolic flux 
analysis (MFA) provides rigorous quantification of microbial flux distributions, 
13
C-
Fingerprinting offers a relatively quicker and simpler qualitative method of testing pathway 
activities, identifying carbon and nutrient contributions, and calculating true product yields 
(Hollinshead et al. 2016; Varman et al. 2014).  
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Figure 2.1 
13
C-Metabolism Analysis: Qualitative vs. Quantitative Approach 
As displayed by the above figure,
13
C-MFA is the quantitative method that expands upon 
13
C-fingerprinting to provide precise flux estimates of several central pathways through 
mathematical modeling. The theory behind this method lies in an important assumption typically 
applicable to batch cultures during the exponential phase and chemostat cultures: that the cells 
have reached metabolic steady state. Using the stoichiometry of the metabolic network, the mass 
isotopomer distributions (MIDs) of the amino acids, and the extracellular rates, several available 
flux softwares will be able to compute close estimates of the flux distribution in the central 
metabolism. Despite its wealth of information, 
13
C-MFA may not be suitable, if the microbial 
strain fails to reach either isotopic and/or metabolic steady state, has a poorly annotated 
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metabolic network, or cannot be cultured without complex or undefined carbon nutrients. In 
addition, it typically takes weeks or even months to completely resolve the fluxes by applying 
13
C-MFA, thus it is a more labor-intensive and time-consuming project to perform rigorous flux 
analysis for multi-strains as compared to 
13
C-Fingerprinting. 
Here, we present an easy-to-follow protocol for 
13
C-Fingerprinting., the qualitative method, 
which using a carefully designed selection of 
13
C-tracers can be used to resolve the cell 
metabolism without complex flux calculations. First, it can be used to probe the activities of 
different pathways if the differing pathways have unique labeling patterns. For example, [1-
13
C] 
glucose has been extensively used to test glycolytic preference between Embden-Meyerhof-
Parnas Pathway (EMPP) and Entner-Doudoroff Pathway (EDP), as the two pathways produce 
two distinctly different labeled pyruvates from glucose: a third position 
13
C-labeled pyruvate and 
a first position 
13
C-labeled pyruvate, respectively. Second, carbon and nutrient contributions to 
biomass synthesis can be easily revealed through the use of a fully labeled primary carbon 
substrate (i.e., [U-
13
C6) glucose) with unlabeled secondary substrates (i.e., yeast extract). The 
13
C/
12
C ratio of the generated biomass provides a measurement of a carbon source’s contribution 
to biomass in a mixed-substrate growth medium. Finally, the intrinsic product yield from the 
primary carbon source can be calculated based on its measured contribution to the final product. 
After your selection of the 
13
C-tracers, the method only then requires growth on the 
13
C tracer, 
amino acid extraction, and determination of mass isotopomer distribution (MID) through mass 
spectrometry (see Figure 2.2). In addition to the qualitative approach of 
13
C- metabolism 
analysis, we will also present the method of quantification of intracellular flux distributions. 
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2.2 Materials   
2.2.1  13C-labeling Growth Experiment 
1. 13C-tracer Selection: The selection of the 13C-tracers is highly dependent on the 
organisms of interest, which carbon metabolism is to be studied and which tracer will 
provide the most information for flux resolution. Table 1 list the most commonly used 
tracers which are available from chemical manufacturers such as Sigma Aldrich (St. 
Louis, MO) or Cambridge Isotopes (Tewksbury, MA). Most commonly, the glucose 
metabolism of a heterotrophic organism is studied using only a labeled glucose substrate 
or a mixture of labeled and unlabeled glucose. For 
13
C-MFA approaches, using one 
labeled glucose substrate over a mixture leads to better resolution, with the optimal 
tracers being [1, 6-
13
C] glucose, [5,6-
13
C] glucose, or [1,2-
13
C] glucose (Crown et al. 
2016).  
Table 2.1 Commonly Used Tracers 
Substrates Commonly Used Tracers 
Glucose [U-
13
C6] Glucose or Positional Labeled Glucose (e.g., [1-
13
C1] Glucose, [2-
13
C1] 
Glucose, [1,2-
13
C2] Glucose, [1,6-
13
C2] Glucose, etc.) 
Acetate [U-
13
C2] Acetate, [1-
13
C1] Acetate, or [2-
13
C1] Acetate 
Pyruvate [U-
13
C3] Pyruvate, [1-
13
C3] Pyruvate, [1,2-
13
C2] Pyruvate, etc.  
Amino acids [U-
13
C3] Aspartate, [U-
13
C3] Glutamate, etc. 
Others 
13
C-Formate, 
13
CO2 or NaH
13
CO3 
 
2. Media Selection: Rich media often contains complex or even undefined carbon sources 
such as yeast extract or casamino acids, which will interfere in both qualitative and 
quantitative analysis. Therefore it is necessary to use a minimal media without any major 
carbon sources beside the 
13
C tracer (and 
12
C tracer as designed for the experiment) or at 
least a well-defined media. Although it should be avoided, the addition of vitamin for 
growth typically has a negligible effect on the results.  
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2.2.2 Measurement of Growth and Extracellular Rates 
1. UV-vis Spectrometer 
2. HPLC or enzymatic assay kits for measurement of extracellular consumption and 
secretion 
2.2.3 Free Metabolite Extraction  
1. Liquid nitrogen 
2. 100 mL Dewar 
3. Methanol-Chloroform (7:3) solution 
4. Lyophilizer  
2.2.4 Amino Acid Extraction 
1.  Saline Solution: 0.9 % (wt/vol) NaCl  
2. 6N HCl  
3. Oven (capable of reaching 100
O
C) 
4. Evaporator: Mini-Vap Evaporator/Concentrator (Sigma Aldrich #22971) or Reacti-Vap 
Evaporators (ThermoFisher Scientific TS-18825)  
5. Drying Gas: N2 or Air; (see Note 1) 
2.2.5 Derivatization and GC-MS Analysis 
(Free Metabolite Derivatization) 
1. MOX reagent: 20 mg/mL methoxyamine hydrochloride in pyridine (prepared fresh) 
2. N-Methyl-N-(trimethylsilyl) trifluoroacetamide (MSTFA)  
3. GC vials 
or 
(Proteinogenic Amino Acid Derivatization) 
1. Tetrahydrofuran 
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2. N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide (TBDMS), 97% 
3. GC vials 
and 
4. Gas Chromatography (Column HP-5MS or DB-5S)-Mass Spectrometer (Alternative 
analytical equipment can be used such as NMR, however be careful to match the instrument 
with the available input format of your 
13
C-MFA software.)   
5. Amino Acid Standards (Optional) (see Note 2) 
2.2.6 Flux Calculation  
To reduce modeling challenges, mass spectrum data correction tools and 13C-MFA software 
have been developed, including FiatFlux (Zamboni et al. 2005), iMS2Flux (Poskar et al. 2012), 
INCA (Young 2014), METRAN (Yoo et al. 2008), OpenFLUX (Quek et al. 2009), OpenMebius 
(Kajihata et al. 2014), 13CFLUX (Wiechert et al. 2001) and 13CFLUX2 (Weitzel et al. 2013). 
The following table shows comparisons among different 
13
C MFA softwares. Researchers may 
choose an ideal software based on the purposes of their studies. 
 
Table 2.2 
13
C-MFA Software (He et al. 2016) 
Software INCA METRAN WUFlux OpenFLUX 13CFLUX2 OpenMobius 
Isotopically 
nonstationary  
flux analysis 
      
Open-source       
Having interface       
Flux visualization       
Built-in MID 
corrections  
      
Tracer simulation       
No need to construct 
flux model and define 
carbon transitions 
      
Reference 
(Young 
2014) 
(Yoo et al. 
2008) 
(He et al. 
2016) 
(Quek et al. 
2009) 
(Weitzel et 
al. 2013) 
(Kajihata et 
al. 2014) 
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Our laboratory has built a 
13
C-MFA software, WUFlux, featuring different templates for 
bacterial metabolism. WUFlux has a predefined central metabolic network and straightforward 
interface and functions for flux map visualization. These features reduce the work required for 
users, and thus make WUFlux straightforward to use. On the other hand, if researchers need to 
apply isotopically nonstationary flux analysis, we recommend INCA or OpenMebius. These two 
softwares have functions for fitting the dynamics of isotopic labeling of metabolites, which is 
extremely useful for analyzing the flux phenotype of autotrophic metabolism. 
2.3 Methods   
2.3.1 Build Metabolic Model  
Initially, in order to rigorously calculate the fluxes in the central metabolism, a complete 
metabolic model must be developed based on the strain’s genome annotations. This often 
restricts this quantitative technique to strains that have been fully sequenced. For information on 
which genes are present, the KEGG database is a superior resource. In addition, the carbon 
transition within the network needs to be known as well. This is pre-set in WUFlux. 
2.3.2 13C-labeling Experiments  
1. Prepare a seed culture: Grow the strain in its unlabeled medium into the mid-exponential 
phase. 
2. Inoculate into the labeled medium at a low inoculation ratio (<0.5 v/v %) (see Note 3). 
3. Grow the cells into the mid-exponential phase, and take biomass samples at three or more 
time points (see Note 4-5).  
4. Centrifuge the samples (7000 rpm, 3min, 4oC), keep the supernatant for extracellular 
consumption and secretion measurements, and keep cell pellets for free 
metabolite/proteinogenic amino acid extractions. 
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2.3.3 Free Metabolite Extraction and Derivatization 
1. Add 1 mL of methanol-chloroform (volume ratio 1:1) extraction solution to the cell pellet. 
Important: Keep samples cool throughout the extraction. 
2. Shake samples (in GC vials) for four hours or overnight at 4OC and 200rpm. 
3. Add 0.5 mL of ultra-pure water (the samples should form an aqueous and an organic 
layer.)  
4. Extract the aqueous layer into new GC vials and freeze-dry the samples using a 
lyophilizer. At this step, the dried samples are stable and can be stored at -20
O
C for 
several days to weeks. 
5. To derivatize the free metabolites, add 120 µL of MOX reagent and incubate samples at 
30
O
C for 40 minutes. 
6. Add 180 µL of MSTFA derivatizing reagent and incubate the mixture at 30OC for 30 
minutes. After derivatization, samples should be run on the GC-MS immediately. The 
samples typically remained stable for about ~4 hours after derivatization. 
2.3.4 Proteinogenic Amino Acid Extraction and Derivatization 
1. Wash cells with 1 mL of saline solution. 
2. Add 1.5 mL of 6N HCl to cells, and then transfer into GC-vials. Tightly cap the GC vials, 
and then place the samples in an oven at 100
O
C for 18-24 hours. 
3. Remove hydrolyzed samples and then cool to room temperature. Transfer the samples to 
micro-centrifuge and spin down to remove any cell debris. Evaporate the HCl using an 
evaporator (see Note 6).  At this step, the dried samples are stable and can be stored at      
-20
O
C for several days to months. 
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4. Derivatize the amino acids by adding THF and TBDMS (volume ratio 1:1, and we 
recommend 150 µL for either solution). Heat in an oven at 70
O
C for one hour. Spin down 
to remove any debris (see Note 7).  
5. Dilute the sample with additional THF if the resulting sample has a dark color. Typically, 
the derivatized sample should be a yellow/light brown. A dark color denotes an overly 
concentrated sample. Rarely, the sample might turn green; this likely is a very dilute 
sample that will require decreasing the split ratio for clear peak data. Derivatized samples 
are relatively stable at 4 degrees for 1-3 days, but for best results run samples 
immediately after derivatization (see Note 8).    
 
Figure 2.2 
13
C-Metabolic Flux Analysis Workflow 
2.3.5 GC-MS Analysis 
Use the following settings for GC/MS analysis or any published analytical method. 
Table 2.3 GC/MS settings 
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Parameters Settings 
Split Ratio 1:5 or 1:10 
Injection volume 1 μL 
Carrier gas helium=1.2 mL/min 
Program: 150
O
C for 2 minutes 
3
O
C/min to 280
O
C 
20
O
C/min to 300
O
C 
Hold for 5 min 
m/z range: 60-500 
 
The following table shows proteinogenic amino acids that can be analyzed by GC/MS  using 
TBDMS derivatization (MSTFA-derivatized metabolites not included in this protocol). 
Table 2.4 TBDMS-derivatized Amino Acids (see Note 9) 
Amino Acid Precursor # of carbons M-159/M-85 M-57/M-15 
Alanine PYR 3 158 260 
Glycine 3PG, Serine, CO2+methylene-THF 2 218 (M-85) 246 
Valine PYR 5 186 288 
Leucine PYR, AcCoA 6 200 344 (M-15) 
Isoleucine PYR, OAA 6 200 344 (M-15) 
Proline AKG 5 184 286 
Methionine OAA 4 218 320 
Serine 3PG, Glycine + methylene-THF 3 288 390 
Threonine OAA, GLX+AcCoA 4 376 (M-85) 404 
Phenylalanine E4P, PEP 9 234 336 
Aspartate OAA 4 316 418 
Glutamate AKG 5 330 432 
Lysine OAA, PYR 6 329 431 
Arginine Glu, CO2 6 340 442 
Histidine R5P, Formyl-THF 6 338 440 
Tyrosine E4P, PEP 9 364 466 
 
2.3.6 Correction for Natural Isotope Abundance 
It is necessary to correct the isotopomer distribution data for any influences due to the natural 
abundance of isotopes in carbon, silicon, and other elements that comprised the derivatized 
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metabolites. Wiechert group  (Wahl et al. 2004a) has developed a software to remove this 
influence from the data. 
2.3.7 Flux Calculations by Using Simple Mass balances 
For qualitative analysis, you can generate rough estimates of fluxes using the isotopomer 
distribution. For example, using a balance on pyruvate produced through the three different 
glycolytic pathways from [1-
13
C1] glucose, equations 1-3 were developed. If using the 
proteinogenic amino acids, the equations can also be used with alanine isotopomer distribution: 
 Pyr
100
=
vEDP
2vEDP+2vEMP+
5
3
vOPPP
 
(1) 
 
Pyr
000
=
5
3
vOPPP+v
EDP
+vEMPP
2vEDP+2vEMP+
5
3
vOPPP
 (2) 
 Pyr
001
=
vEMPP
2vEDP+2vEMPP+
5
3
vOPPP
 
(3) 
where vEDP, vEMPP, and vOPPP are the relative fluxes for the ED pathway, EMP pathway, and 
pentose phosphate pathway, respectively. Ixxx is the fraction of the isotopomer, with 1 denoting 
the carbon position of 
13
C (e.g., I001 is the abundance of pyruvate labeled at carbon position 3). 
These equations assume no reversibility of reactions and ignore the influence of intersecting 
pathways (e.g., cataplerotic pathways and biomass formation). The above equations are a balance 
on pyruvate production from the three glycolytic pathways: the ED pathway, EMP pathway, and 
the pentose phosphate pathway. As shown in the graph below, the fluxes generated for a ΔptsG E. 
coli mutant through these simple balances on pyruvate can significantly differ from those 
calculated by a 
13
C-MFA software like WUFlux for the node reactions G6P->F6P (encoded by 
pgi), 6PG-> R5P (encoded by g6pdh), and 6PG->KDPG (encoded by edd).  
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Figure 2.3 Comparison of fluxes determined by Equations (1-3) and those by 
13
C MFA 
2.3.8 Flux Calculations by Using WUFlux 
Here, we demonstrate the general procedures of performing 
13
C MFA with WUFlux. For the 
detailed information, please read the user manual of WUFlux at http://www.13cmfa.org/. 
1. Choose a template. Click ‘Metabolic Reactions’, and then select one template from those for 
chemoheterotrophic bacteria, photomixotrophic/photoheterotrophic cyanobacteria, or vanillin-
degrading bacteria. The following figure shows a screenshot of choosing a model template in 
WUFlux. 
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Figure 2.4 Template selection in WUFlux 
2. Edit metabolic reactions. As shown in the above figure, WUFlux will display central 
metabolic reactions, which includes the Embden–Meyerhof–Parnas pathway, the oxidative 
pentose phosphate pathway, the Entner–Doudoroff pathway, the TCA cycle, the Calvin cycle 
(only in the cyanobacterial template), the C1 (including 5-methyl-tetrahydrofolate and 5,10-
methylene-tetrahydrofolate) metabolism pathway and the anaplerotic pathway. Researchers can 
modify the metabolic network by knocking out reactions that are not present in the bacterial 
metabolism, changing the boundary conditions and defining the reversibility of reactions based 
on the gene annotations.  (See Note 10) 
3. Input experimental data. To import experimental data, click the button ‘Experimental Data’. 
Two types of experiment data are required: the MIDs of metabolites and labeled substrates. As 
for the MIDs, users can either import the data from an Excel file, or input the data manually. 
Each carbon atom of labeled substrate should be defined as the relative abundance of 
13
C atom. 
For example, define [1,2-
13
C2] glucose as [1,1,0,0,0,0] for the corresponding six carbon atoms, 
where the first ‘1’ means the first carbon atom of glucose is 100% 13C-carbon. In addition, two 
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data types are optional: the nonlabeled biomass percentage and the measured fluxes. The former 
is used to remove the non-labeled 
12
C-carbon noises introduced from bacterial inoculation, and 
the latter can help accurately determine the intracellular fluxes. We recommend users to consider 
these two factors when the initial non-labeled biomass in the labeled culture is high or any 
byproduct is significantly produced by the microorganism.  
4. Customize optimization settings. To modify parameters for optimization and statistics, click 
‘Settings’ and then make changes. The MATLAB built-in function ‘fmincon’ is used to solve the 
nonlinear optimization problem. The parameters, TolFun, TolCon, TolX, MaxIter, and MaxFun, 
have the same meanings as described on the website: 
http://www.mathworks.com/help/optim/ug/fmincon.html. The default algorithm of the ‘fmincon’ 
solver is ‘interior-point’. To get the global optimum, 10 or multiple initial guesses are 
recommended. In addition, the Monte Carlo method is employed to calculate the confidence 
interval of fluxes. In this method, WUFlux perturbs the measured data with normally distributed 
noises, whose averages (µ) are zero, and standard deviations (δ) are based on the experimental 
results.  
5. Optimize the flux distributions. To calculate the intracellular flux distributions, click ‘Run’, 
and a pop-up window will appear to show the progress of the on-going calculation. All the flux 
calculations starting from each initial guess will be stored in the file. Once finished, another 
window will appear: Either click ‘Yes’ to continue calculating confidence intervals, or click ‘No’ 
to stop the calculation for the time being. The ‘Start’ button changes to the ‘Continue’ button, 
and you can resume calculating confidence intervals later.  
6. Visualize the results. Click ‘Results’ to see the best fit of flux distributions, confidence 
intervals, and standard deviations. A figure showing the correlation of measured and simulated 
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MID data will be automatically generated on the right side. Additionally, the χ2 test can be 
applied to determine the goodness of fit (shown at the bottom line), which can be used as a 
reference to determine whether the final fitting is statistically acceptable. The interface also has a 
‘Remove results’ button, which allows you to remove the current flux results. However, once 
deleted, the results cannot be recovered.  
 
Figure 2.5‘Results’ in WUFlux 
 
To visualize the flux results with respect to constructed metabolic network, click the button 
‘Generate a flux map’. WUFlux will generate a flux map in a svg file. Further, to see the 
comparison between the simulated and experimental MID of a certain ion fragment, click 
‘Generate an MID figure’ and then choose the corresponding ion fragment. 
2.4  Notes 
1. N2, an inert gas, is a preferred drying gas, though air is a cheaper alternative. 
2. Standards can be helpful for accurate peak identification; however, a cheaper alternative is to 
process an unlabeled biomass sample in parallel to identify the relevant retention times.   
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3. For qualitative analysis, the inoculation ratio can be as high as 1 or 2% (v/v). 
4. Typically for E. coli, we harvest 5 mL of cultures at OD600 ~1.0. Only 5 mg of biomass is 
necessary for amino acid detection via GC-MS analysis. Biomass can be stored at -20
O
C. 
5. Due to the fast turnover of free metabolites, it is best to quench the cells (i.e., halt the 
metabolism) to avoid sudden metabolite changes due to changing environmental conditions. 
Quenching can be completed through fast filtration, cold solvent (ethanol or methanol), or 
cold media. Our preferred method is a combination of cold media (devoid of carbon sources) 
with liquid nitrogen as a coolant.  
6. Large particles will clog the needle of the GC-MS, so closely examine samples prior to GC-
MS run for any remaining cell debris. 
7. If the samples appear a dark brown/black color, it is likely that the biomass amount was too 
high. At this stage, you can dry down 0.5 or 1 mL of the hydrolyzed sample to cut the time. 
8. It is ideal to avoid loading concentrated samples; this will cause oversaturated MS signals 
which leads to an inaccurate isotopomer data. 
9. Cysteine and Tryptophan cannot be measured through this technique. Glutamine and 
Asparagine are reduced in this method to Glutamate and Aspartate, respectively. Due to their 
low abundance, these amino acids may be difficult to analyze in dilute samples: Methionine, 
Threonine, Arginine, and Histidine. In addition, if peaks appear to co-elute with other 
compounds, it may be necessary to decrease the temperature ramp for better elucidation. 
General signs of interference from other compounds are a high M-1 peak. 
10.  In WUFlux, a new reaction in the central metabolism cannot be added in the template, and 
all the carbon transition fates have been pre-defined. But users can add product formation 
reactions in the ‘Metabolic reactions’ section. 
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2.5 Example Case Study: Examine carbon utilization of lignocellulosic 
hydrolysates in Mortierella Isabellina 
 
Mortierella isabellina is an oleaginous fungus that can grow on lignocellulosic sugars: 
acetate, glucose, and xylose. To further understand its carbon utilization while grown on 
lignocellulosic hydrolysates, we designed parallel 
13
C-labeling experiments using the protocol 
described previously where we grew three identical sets of cultures with only one carbon 
substrate fully 
13
C-labeled (glucose, xylose, and acetate) (Ruan et al. 2015). In addition to the 
three substrates, the cells were also provided yeast extract and exposed to lignocellulosic 
inhibitors: furfural and HMF. In combination, the experiments provided a view of each carbon’s 
contribution to biomass when grown with lignocellulosic hydrolysates and its common inhibitors 
(see Fig. 2.4).  The results from 
13
C-fingerprinting experiments showed a significant carbon 
contribution from yeast extract, an added component to the media as a source of nitrogen. That 
glucose was the next most-utilized source for proteinogenic amino acids, in particular for alanine. 
Acetate served as a main source for TCA-derived amino acids, aspartate and leucine, with little 
incorporation into alanine and phenylalanine (total acetate/
13
C% were <5%). The labeling results 
were also an additional confirmation to sugar consumption measurements that while the strain is 
able to simultaneously utilized glucose and acetate, xylose is not heavily used while glucose is 
present.  
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Figure 2.6 Isotopomer Labeling of Amino Acids 
Data was determined from three different tracer experiments, in which only one tracer of 
glucose, xylose, and acetate was fully labeled accordingly. The biomass samples were from the 
middle-log growth phase in which all three substrates were present. (2) Yeast extract also 
contributed to amino acid synthesis. 
Further, to investigate the carbon contributions to lipid synthesis, the labeling in the lipids 
were measured (see Fig. 2.5). There is a high incorporation of acetate into lipids (36% of lipid 
synthesis), despite a lower provided concentration (2 g/L) then glucose in the media (10 g/L). In 
fungi, acetyl-CoA (lipid precursor) synthesis and TCA cycle occur within the mitochondrion, 
while lipid biosynthesis occurs within the cytosol(Shuler and Kargi 2002). Thus, supplying 
acetate in the media likely enhances acetyl-CoA levels within the cytosol, and facilitates lipid 
accumulation in Mortierella isabellina. 
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Carbon source distribution in lipids determined via 
13
C-carbon tracing analysis. (1) The biomass 
sample was from the middle-log growth phase when all three substrates were present. (2) Yeast 
extract also contributed to lipid synthesis. 
 
 
 
 
  
Figure 2.7 Carbon Contribution to Lipid Synthesis 
31 
 
3 Chapter Three: Rapid metabolic analysis of Rhodococcus opacus 
PD630 via parallel 
13
C-metabolite fingerprinting 
This chapter has been reproduced from the following publication: 
Hollinshead, W.D., Henson, W.R., Abernathy, M., Moon, T.S., & Tang, Y.J. Rapid metabolic analysis of 
Rhodococcus opacus PD630 via parallel 
13
C-metabolite fingerprinting. Biotechnology and Bioengineering. 
113 (1):91-100 (2016). (I contributed to metabolism analysis via 
13
C labeling in this paper.)  
Abstract 
For rapid analysis of microbial metabolisms, 
13
C-fingerprinting employs a set of tracers to 
generate unique labeling patterns in key amino acids that can highlight active pathways. In 
contrast to rigorous 
13
C-metabolic flux analysis (
13
C-MFA), this method aims to provide 
metabolic insights without expensive flux measurements. Using 
13
C-fingerprinting, we 
investigated the metabolic pathways in Rhodococcus opacus PD630, a promising biocatalyst for 
the conversion of lignocellulosic feedstocks into value-added chemicals. Specifically, seven 
metabolic insights were gathered as follows: (1) glucose metabolism mainly via the Entner-
Doudoroff (ED) pathway; (2) lack of glucose catabolite repression during phenol co-utilization; 
(3) simultaneous operation of gluconeogenesis and the ED pathway for the co-metabolism of 
glucose and phenol; (4) an active glyoxylate shunt in acetate-fed culture; (5) high flux through 
anaplerotic pathways (e.g., malic enzyme and phosphoenolpyruvate carboxylase); (6) presence 
of alternative glycine synthesis pathway via glycine dehydrogenase; and (7) utilization of 
preferred exogenous amino acids (e.g., phenylalanine). Additionally, a 
13
C-fingerprinting kit was 
developed for studying the central metabolism of non-model microbial species. This low-cost kit 
can be used to characterize microbial metabolisms and facilitate the design-build-test-learn cycle 
during the development of microbial cell factories. 
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3.1 Introduction 
Over the past decades, model organisms such as Escherichia coli and Saccharomyces 
cerevisiae have been engineered to produce diverse products. However, such model organisms 
have struggled to become industrial platforms for producing biochemicals because of the poor 
stability of heterologous enzymes, low product yields and titers, and the high cost of feedstocks. 
An alternative approach is to develop a non-model chassis that natively contains a desired 
pathway or tolerance to substrates and products (Alper and Stephanopoulos 2009). Non-model 
organisms that require only minor modifications to native pathways and regulations could 
improve biosynthesis yields, leading to cost-effective commercial biorefineries. The first step 
towards development of such a new microbial chassis is to understand their metabolism. Recent 
advances in whole genome sequencing as well as RNA profiling and proteomics have lowered 
the time and cost of analyzing organisms, leading to a rapid growth of functional genomics 
(Suthers et al. 2009). However, unknown mechanisms of post-transcriptional and post-
translational regulations still limit our ability to connect microbial “omics” with actual 
phenotypes (Chubukov et al. 2013; Gygi et al. 1999). Fluxomics can fill this gap by directly 
probing enzyme functions.  
13
C-Metabolic Flux Analysis (
13
C-MFA) can estimate in vivo reaction rates in microbial 
central metabolisms. A typical MFA protocol includes chemostat cultures using 
13
C-labeled 
substrates, measurement of extracellular metabolite concentrations, determination of biomass 
compositions, isotopomer analysis of amino acids or free metabolites, development of a 
metabolic model, and flux calculations.  The method can pin-point bottleneck steps in a 
metabolic network and guide metabolic engineering approaches (Fig. 3.1) (Au et al. 2014; 
Crown and Antoniewicz 2013b; Long and Antoniewicz 2014).     
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Figure 3.1 
13
C-MFA and 
13
C-fingerprinting for rational metabolic engineering 
Technical advances in DNA synthesis allow for rapid assembly of a metabolic pathway (often 
within a week). Thus, the need of time-efficient 
13
C-metabolism analysis along with other 
“omics” tools has become essential to address issues resulting from multiple interactions 
between pathways, which ultimately plays an important role in the iterative design-build-test-
learn cycle during rational metabolic engineering. 
 
However, this quantitative determination of flux values in a metabolic network can be 
time consuming. High throughput 
13
C-MFA methodology and equipment are being developed 
(Fischer and Sauer 2005; Heux et al. 2014), which may reduce the cost for mutant 
characterizations during the design-build-test-learn cycle of metabolic engineering. Another 
roadblock is that traditional 
13
C-MFA cannot characterize many microbial systems precisely: 1) 
microbial species that cannot grow in a minimal defined medium; b) cultures that cannot achieve 
a strict metabolic steady state (e.g., biomass compositions of Rhodococcus change due to the 
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accumulation of intracellular lipids); c) consortium or microbial species with sub-populations 
(e.g., engineered microbes often contain both plasmid-containing cells and plasmid-free cells); d) 
13
C-tracers for metabolism analyses (e.g., 
13
C-phenolic compounds for studying aromatic 
substrate utilization) are commercially unavailable or prohibitively expensive. The CeCaFDB 
database indicates that less than 100 
13
C-MFA papers were published on non-model microbes in 
the past 20 years (Zhang et al. 2015).  
Alternatively, 
13
C-tracing via multiple-tracers may elucidate the enzyme activities or 
measure intrinsic biosynthesis yields in a more time-efficient manner (Buescher et al. 2015; 
Varman et al. 2014). In the past, parallel labeling experiments have been used to investigate 
specific pathways (such as TCA cycle or glycolytic pathways) (Crown and Antoniewicz 2013a) 
or improve 13C-MFA accuracy (Crown et al. 2015). In our study, we designed a more 
comprehensive set of tracer experiments to delineate the overall central metabolism of a poorly 
understood microbe. Via a 13C-“fingerprint” (i.e., the labeling distributions of key proteinogenic 
amino acids), we can compare and examine almost all central pathways. As a simplified version 
of 13C-MFA, this method eliminates the need to measure concentrations of extracellular 
metabolites and biomass compositions or metabolic modeling for flux calculations (reducing the 
restrictions on culture medium and culture states). In addition, 13C-experiments that include 
combinations of labeled and unlabeled substrates can elucidate unknown pathways and their 
importance within a non-model organism’s central metabolism. 13C-fingerprinting is particularly 
valuable for qualitatively analyzing poorly-understood microbial species at low costs. As a case 
study, we applied 13C-fingerprinting to investigate the central metabolism of Rhodococcus 
opacus PD630, a promising biocatalyst to convert diverse feedstocks into triacylglycerol.    
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The Rhodococcus genus contains species that are found in many diverse environments, 
including water, termite guts, and contaminated soils (Bredholdt et al. 2007; McLeod et al. 2006; 
Whyte et al. 2002). R. opacus PD630 was isolated from contaminated soil at a gas works plant 
(Alvarez et al. 1996), and it has demonstrated high tolerance to industrial solvents, such as 
benzene and toluene (Nakashima et al. 2005; Paje et al. 1997; Zaitsev et al. 1995). It is 
hypothesized that its solvent tolerance is due to its unique lipid metabolism and capacity for 
triacylglycerol accumulation(Urbano et al. 2014). This species can accumulate up to 70-80% of 
its cell dry weight as triacylglycerol (TAG)(Alvarez et al. 1996). When grown on three different 
lignocellulose hydrolysates, PD630 was able to maintain growth and accumulate TAG(Wang et 
al. 2014). In addition, Kurosawa et al. have developed genetic tools to engineer this strain for co-
utilization of glucose and arabinose, making R. opacus PD630 a promising workhorse for 
lignocellulosic biofuel production(Kurosawa et al. 2015). To further explore this strain’s 
potential, we used 
13
C-fingerprinting to have a better understanding of its annotated metabolic 
network (Holder et al. 2011).   
3.2 Results  
3.2.1  Growth of R. opacus PD630 on different carbon substrates 
One of the most promising characteristics of R. opacus is its ability to grow on a variety 
of carbon substrates, including toxic aromatics. To delineate the effect of each carbon source, R. 
opacus was grown in 5 mL of tracer media. These growth experiments can offer preliminary 
information on bacterial carbon utilizations. As shown in Table 3.1, the culture with glucose and 
yeast extract had the highest growth rate (0.25 hr
-1
) while the acetate culture had the lowest 
growth rate (0.16 hr
-1
). The culture with both glucose and phenol did not show a reduced growth 
rate (0.22 hr
-1
), compared to that of the culture with glucose only (0.19 hr
-1
). Moreover, addition 
of other substrates (i.e., glyoxylate and malate) to glucose cultures did not inhibit cell growth.  
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Table 3.1 Tracer experiments for 
13
C-fingerprinting in R. opacus PD630 
Pathway Growth Substrate 
Growth Rate  
(hr
-1
) 
13
C-fingerprints in key 
amino acids 
Amino acid 
uptake 
5 g/L U-
13
C6 glucose + 0.5 g/L 
yeast extract 
0.25±0.02 
12
C abundance in amino 
acids 
Acetate 
metabolism 
2.5 g/L 1-
13
C1 acetate 0.16±0.01 
13
C  labeling in Ala, Asp, 
Glu, Gly, Ser 
CO2 fixation 
5 g/L U-
13
C6 glucose + 1 g/L 
NaHCO3 
0.24±0.01 
13
C  labeling in Ala, Asp, 
Glu 
Glucose 
metabolism 
5 g/L 1-
13
C1 glucose 0.19±0.01 
13
C  labeling in Ala 
Glyoxylate 
shunt 
5 g/L U-
13
C6 glucose  + 0.5 g/L 
glyoxylate 
0.24±0.01 
12
C abundance in Ala, Asp 
and Gly 
Glyoxylate 
shunt 
2.5 g/L U-
13
C2 acetate + 0.5 g/L 
glyoxylate 
0.20±0.03 
12
C abundance in Ala, Asp, 
Gly, Phe 
Malic enzyme 
5 g/L U-
13
C6 glucose + 0.5 g/L 
malate 
0.21±0.01 
12
C abundance in Ala, Asp, 
Phe 
Phenol co-
metabolism 
5 g/L U-
13
C6 glucose + 0.5 g/L 
phenol 
0.22±0.01 
12
C abundance in Ala, Asp, 
Glu, Phe, Ser 
 
3.2.2 Glucose catabolic pathways in R. opacus PD630 
Glucose can be catabolized into pyruvate by three routes: the Embden-Meyerhof pathway 
(EMP), the pentose phosphate (PP), and the Entner-Doudoroff (ED) pathways (Fig. 3.2). The 
EMP produces two ATP and two NADH molecules per glucose molecule. In conjunction with 
the EMP, the PP pathway synthesizes C4/C5 building blocks and replenishes NADPH supply. 
The first step of the PP pathway converts glucose-6-phosphate (G6P) into 6-
phosphogluconolactone (6PG) via glucose-6-dehydrogenase. 6PG acts as a branching metabolite 
between the oxidative PP pathway (6PG  ribulose 5-phosphate + CO2) and the competing ED 
pathway. The ED pathway relies on 6PG dehydratase and 2-keto-3-deoxyphosphogluconate 
aldolase, which has a net yield of one ATP, one NADH, and one NADPH per glucose molecule.  
 1-
13
C glucose can be used to distinguish the relative flux between the three glucose 
degradation pathways by analyzing the labeling of alanine (a pyruvate-derived amino acid) 
37 
 
(Klingner et al. 2015). As shown in Fig. 2, EMP pathway of 1-
13
C glucose produces one 
unlabeled pyruvate molecule and one pyruvate molecule labeled at carbon position 3 (i.e., 50% 
of alanine will be labeled on its third carbon, and 50% of alanine will not be labeled). If 1-
13
C 
glucose is metabolized via the oxidative PP pathway, the labeled carbon will be lost, resulting in 
unlabeled pyruvate(Borodina et al. 2005). In contrast, the ED pathway produces pyruvate labeled 
at position 1 (i.e., 50% of alanine is labeled on its first carbon, and 50 % of alanine is not 
labeled). In this study, alanine was labeled at position 1 (~47%). Eq. 2-4 shows ~93% of glucose 
was catabolized via the ED pathway, while the EMP (~2%) and the PP pathway (~5%) had low 
activity. The ED pathway can also be revealed by serine labeling (derived from GAP, Fig. 2). 
When 1-
13
C glucose was used by R. opacus, the resulting serine was almost unlabeled (M0>95%, 
Supplementary Table S1), confirming low EMP pathway flux. For comparison, E. coli has low 
activity of its ED pathway(Zhao and Shimizu 2003b). A control experiment confirmed that 
alanine from  E. coli culture with 1-13C glucose was labeled at its third position (Fig. 3.2). 
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Figure 3.2 1-
13
C glucose catabolism via the ED, EMP, and oxidative PP pathways 
The relative amounts of three key isotopomers of alanine were calculated based on GC-MS data 
([M-57]+, [M-159]+, and f302 peaks). Alanine from R. opacus was mainly labeled at its first 
position or unlabeled. *: Alanine resulting from 1-
13
C glucose culture of E. coli BL21 (as a 
control) was mainly labeled at its third position. Abbreviations: KDPG, 2-keto-3-deoxy-6-
phosphogluconate; GAP, glyceraldehyde-3-phosphate; PYR, pyruvate; FBP, fructose-1,6-
biphosphate; DHAP, dihydroxyacetone phosphate;  Ru5P, ribulose-5-phosphate. 
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3.2.3 Activation of glyoxylate shunt in acetate metabolism in R. opacus PD630 
The glyoxylate shunt utilizes isocitrate lyase and malate synthase, eliminates the loss of 
carbon as CO2, and replenishes the TCA cycle with intermediate metabolites (Fig. 3.3). To detect 
whether the glyoxylate shunt was active, R. opacus was cultivated in fully labeled glucose (U-
13
C) with unlabeled glyoxylate. Analysis of the resulting amino acids showed that oxaloacetate-
derived Asp was almost fully labeled (two-carbon labeled Asp M2 below 5%), indicating low 
glyoxylate shunt activity in glucose-fed cultures (Table 3.2). Changing the primary carbon 
source to acetate (i.e., fully labeled acetate and unlabeled glyoxylate) significantly up-regulated 
the glyoxylate shunt to co-utilize glyoxylate, as shown by the isotopic dilution of Asp. The 
incorporation of unlabeled carbons from glyoxylate into malate also leads to isotopic dilutions of 
pyruvate-derived alanine, indicating pyruvate shunt activity. In bacteria, isocitrate lyase has a 
much lower affinity for isocitrate than isocitrate dehydrogenase in the TCA cycle. However, 
acetate metabolism deactivates isocitrate dehydrogenase and thus increases isocitrate channeling 
through the glyoxylate shunt (Zhao and Shimizu 2003b). 
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Figure 3.3 Metabolic network of Rhodococcus opacus PD630  
Central pathways include EMP, pentose phosphate pathway (PPP), ED pathway (green arrows), 
glyoxylate shunt, anaplerotic pathways (blue arrows), and the TCA cycle. Phenol is degraded 
into SucCoA and Acetyl-CoA (red arrows) that can be used for growth and lipid biosynthesis 
(Holder et al. 2011). Labeling patterns for cultures with glucose and phenol as carbon sources 
suggest that the use of the ED pathway for glucose metabolism allows for gluconeogenesis via 
the EMP pathway (purple arrows). Dotted lines represent pathways for amino acid biosynthesis. 
Abbreviations: α-KG, α-ketoglutarate; GLX, glyoxylate; ICIT, isocitrate; MAL, malate; OAA, 
oxaloacetate; PEP, phosphoenolpyruvate; SUC, succinate; SucCoA, succinyl-CoA.  
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 As seen in cultures grown in 1-
13
C acetate only, the labeling of alanine is similar to that 
of serine and serine-derived glycine (Table 3.2). However, cultures fed with both fully labeled 
acetate and unlabeled glyoxylate resulted in glycine with unusually high abundances of M0 
(0.57). Similar observation was also found in the U-
13
C Glucose culture with unlabeled 
glyoxylate (i.e., M0 in glycine was much higher than M0 of other amino acids, such as Asp). This 
large M0 of glycine indicates a direct conversion of glyoxylate to glycine in the presence of 
extracellular glyoxylate. A unique glycine dehydrogenase in Mycobacterium species has been 
discovered to convert glyoxylate to glycine(Boshoff and Barry 2005), which is involved in redox 
balancing and intracellular detoxification of fatty acid by-products in Mycobacterium 
species(Giffin et al. 2012). However, this reaction is not annotated in the R. opacus KEGG map. 
A search using the KEGG genome database shows two genes that are annotated as glycine 
dehydrogenases, LPD04987 and LPD07163. They share a 77% and 63% protein sequence 
identity to the glycine dehydrogenase found in M. tuberculosis (mtu:Rv1832), respectively. We 
performed RT-PCR to determine whether the annotated glycine dehydrogenases were actually 
transcribed in R. opacus. As shown in Figure 3.4, both candidate genes of glycine dehydrogenase 
were expressed (especially for LPD04987).  
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Table 3.2 MS data ([M-57]
+
) in key non-fragmented amino acids resulting from 
13
C-
fingerprinting 
Labeled 
Substrate 
Unlabeled 
Substrate 
Amino 
Acid 
M0 M1 M2 M3 M4 
U-
13
C 
Glucose 
Bicarbonate 
Asp 0.00±0.01 0.00±0.01 0.01±0.01 0.11±0.01 0.87±0.01 
Ser 0.01±0.01 0.00±0.01 0.03±0.01 0.96±0.01 
 
Malate 
Ala 0.15±0.02 0.02±0.01 0.04±0.01 0.79±0.02 
 
Asp 0.24±0.04 0.03±0.01 0.05±0.01 0.13±0.01 0.56±0.05 
Phe 
(M0-
M4) 
0.02±0.01 0.03±0.01 0.01±0.01 0.02±0.01 0.06±0.01 
Phe 
(M5-
M9) 
0.02±0.01 0.05±0.01 0.05±0.01 0.08±0.01 0.67±0.04 
Ser 0.11±0.02 0.03±0.01 0.05±0.01 0.81±0.02 
 
Glyoxylate 
Asp 0.01±0.01 0.00±0.01 0.05±0.01 0.15±0.01 0.80±0.01 
Ser 0.01±0.01 0.02±0.01 0.04±0.01 0.94±0.01 
 
Ala 0.01±0.01 0.01±0.01 0.04±0.01 0.95±0.01 
 
Gly 0.08±0.01 0.03±0.01 0.89±0.01 
  
U-
13
C 
Acetate 
Glyoxylate 
Asp 0.10±0.01 0.13±0.01 0.16±0.01 0.14±0.01 0.46±0.01 
Ala 0.21±0.01 0.05±0.01 0.32±0.01 0.42±0.01 
 
Ser 0.44±0.01 0.07±0.01 0.07±0.01 0.42±0.01 
 
Gly 0.57±0.01 0.06±0.01 0.38±0.01 
  
1-
13
C 
Acetate 
None 
Ala 0.40±0.02 0.59±0.02 0.01±0.02 0.00±0.02 
 
Gly 0.42±0.02 0.59±0.02 0.00±0.02 
  
Ser 0.41±0.02 0.59±0.02 0.00±0.02 0.00±0.02 
 
 
* Mass standard deviations are estimated based on two replicate samples (n=2). The instrumental 
errors of GC-MS measurement were below 0.02. Note: Unlike 
13
C-MFA,
 13
C-fingerprinting 
analyses depend on labeling data from only a few key amino acids.  
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Figure 3.4 RT-PCR results for the annotated glycine dehydrogenases. 
Figure is a representative image of RT-PCR experiments (biological duplicate for cultures grown 
in 5 g/L glucose and 0.5 g/L glyoxylate). Lane 1, size ladder (150, 200 nt, etc. from the bottom); 
Lane 2, LPD07163 (195 nt); Lane 3, LPD04987 (193 nt); and Lane 4, reference gene LPD05856 
(positive control, 146 nt). No band was observed from negative control samples (control without 
template).  
 
3.2.4 Activities of anaplerotic pathways and malic enzyme in R. opacus PD630 
Anaplerotic pathways allow heterotrophs to fix CO2, regulate the cofactor balance, and 
replenish TCA metabolites. The enzymes responsible for the anaplerotic pathways are the malic 
enzyme, phosphoenolpyruvate carboxylase, and pyruvate carboxylase. If the anaplerotic 
reactions are absent in microbial hosts, cell metabolism has to employ glyoxylate shunt to 
regulate the TCA cycle(Peng et al. 2004). To investigate the anaplerotic activity, fully labeled 
glucose and unlabeled bicarbonate were used to detect R. opacus CO2 fixation (Table 3.2), which 
would lead to a labeling dilution in TCA cycle metabolites. Isotopomer analysis indicates that 
the oxaloacetate-derived Asp displayed 11% M3 (i.e., one carbon of Asp was from unlabeled 
CO2), and very little labeling dilution was seen in Ala or Ser. This indicates that CO2 fixation is 
likely through the phosphoenolpyruvate carboxylase (PEPC) or pyruvate carboxylase.  
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On the other hand, the malic enzyme allows the exchange of TCA intermediates with 
pyruvate for NADPH generation. The malic enzyme activity was revealed using fully labeled 
glucose and unlabeled malate (Table 3.2). The labeling in Asp was highly diluted from the 
incorporation of unlabeled malate through the TCA cycle. Labeled alanine also became diluted 
with an abundance of 0.15 for M0, indicating pyruvate shunt activity. The dilution in the labeling 
of serine (derived from glyceraldehyde 3-phosphate) and phenylalanine (derived from 
phosphoenolpyruvate, PEP) supports the activity of PEP carboxykinase (PEPCK), which 
converts oxaloacetate into PEP. Since the PYR-to-PEP conversion is thermodynamically 
unfavorable (Zhao and Shimizu 2003b), PEPCK is likely a key route to pump carbons from the 
TCA cycle into upper glycolysis intermediates in R. opacus PD630. 
3.2.5 Amino acid and phenol utilization in R. opacus PD630 
Microbial preference for using exogenous amino acids is associated with their ABC-
transporters(Zhuang et al. 2011). To explore this preference, cells were grown with fully labeled 
glucose and unlabeled yeast extract. In this rich medium, cell growth was ~25% faster (Table 
3.1). As shown in Fig. 4, 66% of the carbon from Phe was incorporated from unlabeled yeast 
extract at the mid-exponential phase, likely due to the strain’s ability to transport aromatic 
compounds (e.g., benzoate) inside the cell for growth. The data also shows exogenous uptake of 
Tyr (41%), another aromatic amino acid (Fig. 3.5). Furthermore, addition of 0.5 g/L Phe into 
glucose (5 g/L) medium increased the final biomass (at stationary growth phase) by 26%, 
indicating R. opacus’ capability to catabolize Phe as the secondary carbon source.  
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Figure 3.5 The use of exogenous amino acids from yeast extract by R. opacus 
From a tracer experiment (U-
13
C glucose) with unlabeled yeast extract, the 
12
C % abundance 
represents the percentage of carbon that is not derived from glucose. Error bars represent 
standard deviations from GC-MS measurements (n=2).  
 
 R. opacus can grow on toxic aromatics primarily via the β-ketoadipate pathway 
(Harwood and Parales 1996). This pathway contains a meta- and an ortho-cleavage branch that 
cleave the aromatic ring based on the functional groups present. To probe the co-metabolism of 
glucose and phenol, we grew R. opacus with fully labeled glucose and unlabeled phenol. Fig. 3.6 
shows high 
12
C abundance (~70%) in amino acids derived from the TCA cycle (such as Asp and 
Glu), which confirms that R. opacus converts phenol into TCA cycle intermediates (acetyl-CoA 
and succinyl-CoA) via the β-ketoadipate pathway (Fig. 3.3). During the co-utilization of 
unlabeled phenol with 
13
C-glucose, amino acids derived from the EMP, the ED, or the PP 
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pathway also showed significant 
12
C abundance (25 to 50%), verifying that phenolic carbons can 
percolate through the entire central metabolic network during glucose catabolism. Furthermore, 
two different glucose concentrations (1 and 5 g/L) with the same phenol concentration (0.5 g/L) 
were tested, but the 
12
C abundances in the resulting amino acids were almost identical. The lack 
of inhibition on phenol utilization at higher glucose concentrations indicates that glucose does 
not induce catabolite repression on phenol utilization.  
 
Figure 3.6 The contribution of unlabeled phenol to synthesis of R. opacus proteinogenic 
amino acids 
White bar: 
12
C % abundance from two tracer experiments using 0.5 g/L of phenol with 1 g/L U-
13
C glucose. Black bar: 0.5 g/L of phenol with 5 g/L of U-
13
C glucose. The 
12
C abundance of 
amino acids derived from the TCA cycle suggests that much of the carbon from phenol enters the 
TCA cycle (via the β-ketoadipate pathway). Significant 12C % in amino acids derived from the 
EMP, the ED, or the PP pathway suggests that carbon from phenol also entered gluconeogenesis. 
The error bars represent standard deviations from GC-MS measurements (n = 2). 
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Discussion 
This study investigated R. opacus PD630, a promising host for lignocellulosic biomass 
conversion. We discovered several interesting features of R. opacus PD630's metabolism. First, 
R. opacus PD630 was found to have strong preference for the ED pathway. Many archaea use 
the ED pathway, and a few Gram-negative bacteria have been reported to substitute the ED 
pathway for EMP pathway mostly due to a lack of enzymes essential for EMP pathway. For 
example, Roseobacter denitrificans does not have 6-phosphofructokinase and relies on the ED 
pathway for glucose metabolism (Tang et al. 2009a). Previous 
13
C-MFA studies on antibiotic-
producing actinomycete strains Nonomuraea sp. and Streptomyces tenebrarius also reported a 
highly active ED pathway (Borodina et al. 2005; Gunnarsson et al. 2004). Although less ATP-
efficient, the ED pathway has no carbon loss and requires fewer enzymes for glucose catabolism, 
which can increase metabolic flexibility and reduces the burden of synthesizing glycolysis 
enzymes. The ED pathway was also proposed as a necessary trait for increased tolerance to 
oxidative stress in environmental bacteria, such as soil bacteria (e.g., Pseudomonas) and marine 
bacteria (e.g., Alphaproteobacteria) (Chavarría et al. 2013; Flamholz et al. 2013; Klingner et al. 
2015). The ED pathway also generates NADPH, thus lowering the dependence on the PP 
pathway for carbon oxidation and NADPH supply. The ED pathway is vital for accumulation of 
intracellular storage compounds, such as poly-3-hydroxybutyrate in E. coli, because this pathway 
increases the availability of acetyl-CoA and NADPH (Hong et al. 2003). Recent reports indicate 
that engineering the ED pathway in E. coli can reduce metabolic burdens and improve cellular 
NADPH/NADP
+
 ratio for chemical synthesis (Ng et al. 2015; Zhang et al. 2014).  
We have found that R. opacus PD630 can operate an active glyoxylate shunt. We also 
uncovered the activity of unannotated glycine dehydrogenase, which is present in related 
48 
 
Mycobacterium and Rhodoccocus species (Feisthauer et al. 2008; Tang et al. 2009b). Moreover, 
13
C-fingerprinting results suggest the anaplerotic reactions for CO2 fixation, cofactor balancing, 
and metabolite synthesis in R. opacus PD630. Based on genome annotation, the enzymes 
responsible for the anaplerotic pathways are the malic enzyme (LPD02638), 
phosphoenolpyruvate carboxylase (LPD01702), and pyruvate carboxylase (LPD01846). Our 
RNA-seq data showed the high expression of these enzymes in R. opacus cultures with glucose 
or phenol (unpublished results), confirming our finding by 
13
C-fingerprinting. High fluxes 
through anaplerotic pathways can increase R. opacus’ carbon and cofactor flexibility for 
biosynthesis. For example, malic enzyme supports lipid accumulation as the pyruvate shunt 
increases both NADPH and carbon availability for lipid synthesis (Zhang et al. 2007). PEP 
carboxykinase would allow metabolites produced from phenol degradation to be converted into 
gluconeogenesis intermediates, a key strategy for simultaneous use of phenol and glucose.  
Carbon catabolite repression is an important factor for lignocellulosic biofuel production. 
Because multiple forms of substrates are present in degradation mixtures of lignocellulosic 
biomass, simultaneous utilization of carbon sources, such as glucose and aromatics, would 
enable higher productivity. For many microbes, the carbon from secondary substrate may not 
enter all central pathways during their co-metabolism. For example, Mortierella isabellina 
simultaneously uptakes acetate and glucose, but the carbon from acetate is mainly assimilated 
into lipid biosynthesis pathways and the TCA cycle rather than through gluconeogenesis (Ruan 
et al. 2015). During co-utilization of glucose and phenol by R. opacus, metabolites from the 
phenol degradation percolate through the entire metabolic network via both the TCA cycle and 
gluconeogenesis. The two bottleneck steps in the EMP pathway are 6-phosphofructokinase (F6P 
 FBP) and pyruvate kinase (PEP  PYR), both of which are inhibited by ATP and subsequent 
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intermediate metabolites. In gluconeogenesis, two key enzymes, PEP carboxykinase (OAA  
PEP + CO2) and fructose-1,6-bisphosphatase (FBP  F6P), are used to reverse glycolysis flux 
(Mathews et al. 2013). Usually, gluconeogenesis and the EMP pathway are reciprocally 
regulated. In contrast, the ED pathway for glucose catabolism might be a distinctive strategy for 
R. opacus to avoid such regulation, allowing phenol to be incorporated through the 
gluconeogenesis pathway. The activity of the two non-competing pathways (the ED pathway for 
sugar degradation and gluconeogenesis for the assimilation of degradation products from 
aromatic compounds) can explain the absence of catabolite repression during phenol utilization 
in Rhodococcus (Szőköl et al. 2014; Vesely et al. 2007). Interestingly, high fluxes through PEP 
carboxykinase, fructose-1,6-bisphosphatase, and the ED pathway are also found in other 
actinomycete bacteria(Borodina et al. 2005; Gunnarsson et al. 2004).  
Recently, isotopic non-stationary 
13
C-MFAs were developed(Antoniewicz 2015; Young 
et al. 2011). These advanced MFA techniques reduce the duration of labeling experiments and 
improve flux measurement quality. However, quantitative flux analysis is still expensive and 
time-consuming (Supplementary Figure 3.1). Especially, training qualified 
13
C-MFA researchers 
requires extensive practice in modeling, analytical chemistry, and microbiology. Therefore, 
common microbiology laboratory cannot easily perform MFA without collaboration with a 
professional 
13
C-MFA group. Alternatively, 
13
C-fingerprinting only requires comparison of 
metabolite labeling resulting from various 
13
C-cultures. Such qualitative metabolic analysis, 
through measuring a small subset of key amino acids, reduces experimental steps, culture 
volumes, data analysis, and model calculations. To assist labs unfamiliar with 
13
C-pathway 
tracing, we have designed a toolkit (Fig. 6). The prototype kit, similar to micro-cultivation 
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devices (Hermann et al. 2003), has an 8-well block that holds sterilized test tubes for parallel 
labeling experiments. 
  
Figure 3.7 A kit for 13C fingerprinting 
The kit consists of an 8-well block, sterile tubes containing 25 mg of 13C-substrates, and a 
gassing manifold. Microbes can be grown in different combinations of 13C-substrates, each of 
which probes specific pathways as indicated. Custom choices of labeled substrates may target 
novel pathways (such as Re-citrate synthase, citratemalate pathway, C1-metabolism, etc.) in 
nonmodel species as described in our previous paper (Tang et al. 2012).  
Each test tube contains a 
13
C-tracer (~25 mg) or a mixture of 
12
C- and 
13
C-tracers to probe 
targeted pathways. Since only proteinogenic amino acids are used for pathway analysis, a 4-6 
mL culture volume is sufficient. A small culture volume reduces 
13
C-substrate costs and provides 
good biomass growth (Supplementary Table 3.2). After cultures enter exponential phase, the 
biomass can be harvested and hydrolyzed (note that the block of the kit can be used for drying 
amino acid solutions). The manifold can also aerate the cultures during cultivation. With this kit, 
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users do not need to order large amounts of expensive 
13
C-substrates (standard tracers are often 
sold by ~ grams per order). By using only necessary amounts of tracers, 
13
C-substrate cost can be 
reduced. In addition, tracer experiments, labeling determination by GC-MS, and pathway 
analysis can be completed on the timescale of three days.  
3.3 Conclusion 
The study of non-model species allows for the development of new microbial chassis for the 
biosynthesis of useful products. As tolerance to and utilization of various carbon sources become 
more important for profitability, searching for the ideal microbial host for biochemical 
production becomes important. This study demonstrates that 
13
C-fingerprinting can identify 
interesting metabolic strategies of R. opacus for tolerating and utilizing toxic aromatic 
compounds. Although 
13
C-fingerprinting and comparison of isotopic labeling from various tracer 
experiments cannot draw quantitative metabolic conclusions, this approach provides a time- and 
cost-efficient way to reveal active pathways. To make this approach widely adopted, we 
developed a 
13
C-kit for studying diverse microbes with a previously published tutorial (You et al. 
2012). This kit can expedite the design-build-test-learn cycle of metabolic engineering by 
enabling rapid investigation of microbial cell factories. It may also probe many microbial 
systems that are not amenable to rigorous 
13
C-MFA. 
13
C-fingerprinting provides a 
complementary approach to 
13
C-MFA, which will be our next step for profiling metabolic fluxes 
of R. opacus for co-utilization of both phenolic compounds and sugars. 
3.4 Materials and Methods 
3.4.1 Chemicals, strain, and growth conditions 
13
C-labeled chemicals were from Cambridge Isotope Laboratories (Tewksbury, MA). All other 
chemicals (glucose, glyoxylate, etc.) were purchased from Sigma Aldrich (St. Louis, MO). 
52 
 
Rhodococcus opacus PD630 was grown in defined media at 30°C and 250 rpm using 50 mL 
glass culture tubes. The minimal medium contained 1.0 g MgSO4·7H2O, 0.015 g CaCl2·2H2O, 
1.0 mL trace element solution, 1.0 mL stock A solution, and 35.2 mL 1.0M phosphate buffer 
(Chartrain et al. 1998). The trace element solution contained (per L) 0.5 g FeSO4·7H2O, 0.4 g 
ZnSO4·7H2O, 0.02 g MnSO4·H2O, 0.015g H3BO3, 0.01 g NiCl2·6H2O, 0.25 g EDTA, 0.05 g 
CoCl2·6H2O, and 0.005 g CuCl2·2H2O. The stock A solution contained (per L) 2 g 
NaMoO4·2H2O and 5 g FeNa·EDTA. The phosphate buffer contained (per L) 113 g K2HPO4 and 
47 g KH2PO4. (NH4)2SO4 was used as the nitrogen source (1 g/L). Culture media were filter-
sterilized using a 0.22 μm filter. For all cultures, a single colony from LB agar plates was grown 
in 2 mL of the minimal medium with 5 g/L of glucose for 36-48 hours. This seed culture was 
transferred into 10 mL of unlabeled medium and incubated for 24 hours. The second subculture 
(OD600 ~1) was used as the inoculum for tracer experiments. Eight labeling experiments were 
designed to probe targeted metabolic pathways in R. opacus, as shown in Table I. Each 13C-
culture was inoculated at an initial OD600 of 0.01 (biological duplicate) in 5 mL culture volume. 
Once cells reached mid-exponential phase, they were harvested (by centrifugation) for amino 
acid extraction and gas chromatography-mass spectrometry (GC-MS) analysis.  
3.4.2 Amino acid extraction and GC-MS analysis 
Amino acid extraction and GC-MS analysis were performed as described previously (You et al. 
2012a). In brief, cell pellets were washed with 0.9% (w/v) of NaCl solution, and then hydrolyzed 
in 1.5 mL of 6M HCl at 100
o
C overnight. The resulting amino acids were air-dried, and then 
derivatized by N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide prior to GC-MS analysis. 
The GC-MS condition was described in a previous protocol paper (You et al. 2012). For isotopic 
tracing, we used the fragments [M-15]
+
 or [M-57]
+ 
(containing the entire amino acid backbone), 
[M-159]
+
 (containing the amino acid backbone after loss of its first carbon), and f(302)
+
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(containing the first and second amino acid backbone). The labeling data (i.e., M0, M1, M2, etc.) 
represent fractions of unlabeled, singly-labeled, and doubly-labeled metabolites, respectively. 
The natural isotopic abundance of derivatized amino acids was corrected using a reported 
algorithm (Wahl et al. 2004a). 
12
C abundance in amino acids was calculated by the following 
equation: 
 
 𝐶 𝑓𝑟𝑎𝑐𝑡𝑖𝑜𝑛 = [∑
(𝑛 − 𝑖)
𝑛
𝑛
𝑖
 ∗ 𝑀𝑖]  
12  (1) 
where n is the total number of carbons present in the amino acid, Mi is the intensity of the mass 
isotopomer, and i represents the number of labeled carbons. In addition, by analyzing the mass 
spectra of amino acid fragments, we can obtain individual isotopomer fractions for C2 (glycine) 
and C3 (serine and alanine) amino acids. The isotopomer distribution allows for flux ratio 
estimations (Klingner et al. 2015). Equations 2-4 roughly estimate the influence of the flux ratio 
on the alanine isotopomer distribution: 
 𝐼100 =
𝑣𝐸𝐷
2𝑣𝐸𝐷 + 2𝑣𝐸𝑀𝑃 +
5
3 𝑣𝑃𝑃
 
(2) 
 
𝐼000 =
5
3 𝑣𝑃𝑃 + 𝑣𝐸𝐷 + 𝑣𝐸𝑀𝑃
2𝑣𝐸𝐷 + 2𝑣𝐸𝑀𝑃 +
5
3 𝑣𝑃𝑃
 (3) 
 𝐼001 =
𝑣𝐸𝑀𝑃
2𝑣𝐸𝐷 + 2𝑣𝐸𝑀𝑃 +
5
3 𝑣𝑃𝑃
 
(4) 
where vED, vEMP, and vPP are the relative fluxes for the ED pathway, EMP pathway, and pentose 
phosphate pathway, respectively. Ixxx is the fraction of the isotopomer, with 1 denoting the 
carbon position of 
13
C (e.g., I001 is the abundance of alanine labeled at carbon position 3). The 
above equations were used to obtain the relative flux ratios among the ED pathway, EMP 
pathway, and the pentose phosphate pathway. However, these equations assume that there is no 
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reversibility of reactions or other influential pathways (Wiechert et al. 1997), representing an 
approximate analysis of the three glucose catabolic pathways only towards pyruvate node. 
3.4.3 Reverse Transcription PCR (RT-PCR) 
The KEGG genome database suggests two putative glycine dehydrogenases (LPD04987 and 
LPD07163) that may convert glyoxylate into glycine. To check their gene expression levels, RT-
PCR was performed. 50 mL cultures (with 5 g/L glucose and 0.5 g/L glyoxylate) were grown in 
250 mL baffled flasks to exponential phase and harvested (OD600 ~1) by centrifugation at 4600 g 
for 15 minutes. RNA isolation was performed as described previously with some modifications 
(Hoynes-O'Connor et al. 2015). More details on the RNA extraction and cDNA synthesis can be 
found in the Supplementary Materials. Briefly, RNA was extracted using TRIzol reagent (Life 
Technologies, CA) followed by DNase I treatment using the DNA-free DNA Removal Kit (Life 
Technologies, CA). cDNA was prepared using the AffinityScript QPCR cDNA Synthesis Kit 
(Agilent Technologies, CA). The cDNA from biological duplicates was run in technical triplicate 
to confirm the expression of each gene. One reference gene encoding a putative DNA 
polymerase IV (LPD05856) was used as a positive control. A closely-related homologue of 
LPD05856, ro01702 (>95% sequence similarity), was stably expressed in a variety of conditions 
in a similar strain, Rhodococcus jostii RHA1 (Gonçalves et al. 2006; LeBlanc et al. 2008). 
Primers were either chosen from previous literature or designed using NCBI Primer-BLAST 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/).  
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3.5 Supplementary Materials for Chapter 3 
 
 
 
Estimated itemized costs are listed as follows: 
1 Student training (cost includes “student stipends”) and preliminary studies (*) 
2 Labor costs for 
13
C-culture and metabolite labeling analysis 
3 Labor costs for MFA modeling and flux calculation  
4 
13
C-substrate and medium cost 
5 Substrate/metabolite concentration analysis (using R-Biopharm Enzyme kits) 
6 GC-MS user fee for isotopomer analysis 
7 Lab supplies (tubes, cuvettes, pipettes, vials, etc.)  
8 Other cost (e.g., chemicals, software, dry ice, etc.)  
9 Post-
13
C-MFA (check plausibility of MFA results via additional experiments)  
10 Result summary and paper drafting (labor costs included) 
 
* preliminary studies include: a) finding a defined minimal medium for cell culture, b) 
determining whether the biomass growth can reach a steady state, c) analyzing biomass 
composition (protein, lipid, carbohydrate, RNA, and DNA content), and d) assessing whether the 
cell metabolic network is correctly determined (i.e., are there any mis-annotations?).   
 
Total cost = $185,000 (include overhead cost and training of 
13
C-MFAers);  
Direct cost = ~$85,000 (items 2~9).  
Project period: July 2012~ August 2013  
 
Figure S1: Budgets for a 
13
C-MFA project (Synechocystis 6803 flux analysis) in the Tang 
Lab (You et al., 2014). Quantitative determination of proper flux values in a metabolic network 
is expensive and time-consuming for new users.  
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Reference: You L, Berla B, He L, Pakrasi HB, Tang YJ. 
13
C-MFA Delineates the 
Photomixotrophic Metabolism of Synechocystis sp. PCC 6803 under Light and Carbon Sufficient 
Conditions. Biotechnology Journal. 2014. 9:5. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2. Images of multiple functions of the 
13
C-Fingerprinting Kit. A. Gassing manifold 
for CO2 supply into cyanobacterial cultures. B. Tube cultures on a shaker. C. The kit block can 
be used to hold GC vials for air-drying the solutions of hydrolyzed amino acid.  
  
 
 
 
 
 
 
 
 
 
C A B 
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Table S1.1 Mass Isotopomer Distribution (MID) of Alanine and Serine in 1-
13
C glucose tracer 
experiment (Standard deviation is from two biological duplicates). The MID data revealed a 
highly active ED pathway (See Figure 2).  
Alanine [M-57]
+
 [M-159]
+
 f(302)
+
 Serine [M-57]
+
 [M-159]
+
 f(302)
+
 
M0 0.52±0.04 0.95±0.05 0.51±0.05 M0 0.96±0.03 0.98±0.02 0.96±0.03 
M1 0.47±0.04 0.04±0.05 0.48±0.05 M1 0.04±0.02 0.02±0.01 0.02±0.02 
M2 0.01±0.01 0.01±0.01 0.00±0.01 M2 0 0 0 
 
Note: for TBDMS samples, f(302)+ often has high signal-to-noise ratio. But this peak can be still 
used for qualitative validation of carbon labeling positions in amino acids.     
 
Table S2.2 Growth rate comparison between cultures grown in 50 mL shake tubes versus in our 
13
C-fingerprinting kit on the same shaker (200 rpm). The culture medium for E.coli is 2% 
glucose M9 medium, while R. opacus culture used the minimal medium with 5 g/L glucose as 
described in the section of Materials and Methods. 
 
Table S3.3. Primers used for RT-PCR in this study. 
Primer Sequence (5’ to 3’) 
LPD05856 F  GCTTCTTCGCTGTCTTCTTGC 
LPD05856 R CGACAACAAGTTACGAGCCA 
LPD07163 F CGGTCTGCGATCTGGTTCAC 
LPD07163 R CTTGTGCAGGTTCAGGTGTG 
LPD04987 F CCTGTGCGGTGCAGATGTTC 
LPD04987 R CCAAGCACGCACGTCAACTC 
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Protocols for RT-PCR 
RNA Extraction  
50 mL of cell culture was grown in a 250 mL baffled flask to exponential phase and harvested 
(OD600 ~1) by centrifugation at 4600g for 15 minutes. The supernatant was discarded, and the 
cell pellet was resuspended in 1 mL TRIzol reagent (Life Technologies) and stored at -80°C until 
later use. Within one week, the sample was thawed to room temperature followed by incubation 
at 95°C for 5 minutes and then placed on ice for 5 minutes. After the addition of chloroform, 
samples were centrifuged at 12,000g for 15 minutes at 4°C. The upper aqueous phase was 
removed and resuspended in 100% isopropanol, then centrifuged at 12,000g for 30 minutes at 
4°C to pellet the RNA. The supernatant was discarded and the RNA pellet was washed with 1 
mL of ice cold ethanol and centrifuged at 8000g for 5 minutes at 4°C. The RNA pellet was air 
dried and resuspended in DEPC-treated water. At this step, RNA concentrations ranged from 
1000-5000 ng/μL and A260/A280 values ranged from 1.81-2.05. RNA and DNA concentrations 
were routinely measured at intermediate steps using a NanoDrop 2000c UV-Vis 
spectrophotometer (Thermo Scientific). 
DNase Treatment & RNA Purification 
For DNase treatment, the isolated RNA was treated using the DNA-free DNase Kit (Life 
Technologies, CA). For each sample, 10 μg of RNA was added to a total volume of 50 μL 
containing 5 μL of DNase I Buffer and 2 μL of DNase I. Samples were incubated at 37°C for 30 
minutes, then inactivated by adding 10 μL of the DNase Inactivation reagent and briefly 
vortexing. Samples were then incubated for 2 minutes at room temperature, followed by 
centrifugation at 10,000g for 90 seconds. The supernatant containing the RNA was transferred to 
a new tube and stored at -80°C. After DNase treatment, RNA concentrations ranged from 50-175 
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ng/μL with A260/A280 ratios of 1.72-1.90. Samples were checked for DNA contamination using 
PCR (see below for conditions), and no samples contained bands after DNase treatment. To 
ensure that there were no other contaminants for cDNA synthesis, samples were purified using 
the RNA Clean & Concentrator-5 Kit (Zymo Research) following the kit’s instructions.  
cDNA Synthesis & PCR 
All primers were ordered from Integrated DNA Technologies and their sequences can be found 
in Supplementary Table S3. cDNA synthesis was performed using the AffinityScript QPCR 
cDNA Synthesis Kit following the kit’s instructions. Each sample contained approximately 500 
ng of purified RNA in a 20 μL reaction volume containing 10 μL of cDNA synthesis master mix, 
3 μL of random primers, and 1 μL of Affinity Script RT/RNase Block enzyme mixture. All 
samples were run with the following program: 25°C for 5 minutes, 42°C for 15 minutes, and 
95°C for 5 minutes. PCR was performed using GoTag DNA polymerase (Promega Corporation) 
under the following thermocycler conditions: 95°C for 2 minutes, followed by 40 cycles of 95°C 
for 45 seconds, 60°C for 45 seconds, and 20 seconds at 72°C. After 40 cycles, samples were run 
at 72°C for 5 minutes. Gel electrophoresis to confirm band sizes was performed using a 2% 
agarose gel with SYBR-Safe DNA Gel stain (Life Technologies). PCR without template was 
performed to confirm that no other bands were formed by primers.   
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Supplemental Isotopomer Data Tables (Raw GC-MS data) 
Mass Spectrum (MS) data from analyzed amino acids in the 
13
C-Fingerprinting Experiments. 
Abbreviations used: Ala, Alanine; Gly, Glycine; Val, Valine; Leu, Leucine; Ile, Isoleucine; Ser, 
Serine; Thr, Threonine; Phe, Phenylalanine; Asp, Aspartate; Glu, Glutamate; His, Histidine; Tyr, 
Tyrosine and Mass Isotopomer Distribution (MID). In general, standard errors of amino acid 
labeling analysis using TBDMS method are within 0.02. 
             
1-
13
C Glucose 
Amino 
Acid 
TBDMS 
Fragment 
MID 12C
% M0 M1 M2 M3 M4 M5 M6 M7 M8 M9 
Ala 
[M-57]
+
 0.52 0.47 0.01 0.00       83.6 
[M-159]
+
 0.95 0.04 0.01        97.0 
f(302)
+
 0.51 0.48 0.00        75.0 
Gly 
[M-57]
+
 0.96 0.04 0.00        97.9 
[M-85]
+
 0.97 0.03         97.0 
Val 
[M-57]
+
 0.46 0.52 0.01 0.00 0.00 0.00     89.1 
[M-159
]+
 0.94 0.04 0.00 0.01 0.00      97.5 
Leu 
[M-15]
+
 0.92 0.07 0.01 0.00 0.00 0.00 0.00    98.6 
[M-159]
+
 0.75 0.21 0.04 0.00 0.00 0.00     94.3 
Ile 
[M-15]
+
 0.64 0.30 0.06 0.00 0.00 0.00 0.00    92.9 
[M-159]
+
 0.74 0.24 0.02 0.00 0.00 0.00     94.5 
Ser 
[M-57]
+
 0.96 0.04 0.00 0.00       99.1 
[M-159
]+
 0.99 0.01 0.00        99.5 
 f(302)
+
 0.96 0.02 0.00        97.0 
Thr 
[M-57]
+
 0.66 0.28 0.05 0.00 0.00      90.3 
[M-85]
+
 0.76 0.24 0.00 0.00       92.2 
Phe 
[M-57]
+
 0.87 0.12 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 98.1 
[M-159
]+
 0.90 0.09 0.01 0.00 0.00 0.00 0.00 0.00 0.00  98.3 
Asp 
[M-57]
+
 0.67 0.28 0.05 0.00 0.00      90.6 
[M-159
]+
 0.77 0.22 0.00 0.01       91.7 
Glu 
[M-57]
+
 0.62 0.36 0.03 0.00 0.00 0.00 Note: High standard deviation 92.5 
[M-159
]+
 0.93 0.07 0.00 0.00 0.00      98.2 
His 
[M-57]
+
 0.69 0.29 0.02 0.00 0.00 0.00 0.00    95.4 
[M-159
]+
 0.68 0.29 0.01 0.01 0.00 0.00     94.1 
Tyr 
[M-57]
+
 0.86 0.13 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 97.9 
[M-159
]+
 0.90 0.08 0.01 0.00 0.00 0.00 0.00 0.00 0.00  97.6 
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U-
13
C6 Glucose + Glyoxylate 
Amino 
Acid 
TBDMS 
Fragment 
MID 12C
% M0 M1 M2 M3 M4 M5 M6 M7 M8 M9 
Ala 
[M-57]
+
 0.01 0.01 0.04 0.95       2.5 
[M-159]
+
 0.01 0.04 0.95        3.1 
Gly 
[M-57]
+
 0.08 0.03 0.89        9.7 
[M-85]
+
 0.10 0.90         9.8 
Val 
[M-57]
+
 0.01 0.00 0.00 0.01 0.06 0.93     2.3 
[M-159
]+
 0.01 0.00 0.01 0.06 0.92      2.6 
Leu 
[M-15]
+
 0.00 0.00 0.04 0.13 0.03 0.12 0.68    12.7 
[M-159]
+
 0.01 0.00 0.00 0.01 0.07 0.91     2.5 
Ile 
[M-15]
+
 0.01 0.00 0.02 0.08 0.05 0.18 0.66    11.0 
[M-159]
+
 0.01 0.00 0.01 0.03 0.19 0.77     6.0 
Ser 
[M-57]
+
 0.01 0.02 0.04 0.94       3.0 
[M-159
]+
 0.01 0.04 0.95        3.3 
Thr 
[M-57]
+
 0.01 0.01 0.03 0.15 0.79      7.5 
[M-85]
+
 0.02 0.02 0.16 0.80       8.1 
Phe 
[M-57]
+
 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.09 0.89 2.3 
[M-159
]+
 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.09 0.90  2.1 
Asp 
[M-57]
+
 0.01 0.00 0.05 0.15 0.80      6.9 
[M-159
]+
 0.01 0.02 0.16 0.81       7.5 
Glu 
[M-57]
+
 0.00 0.00 0.00 0.03 0.17 0.80     5.2 
[M-159
]+
 0.00 0.00 0.02 0.09 0.88      3.8 
His 
[M-57]
+
 0.01 0.00 0.01 0.00 0.01 0.06 0.90    3.1 
[M-159
]+
 0.01 0.00 0.00 0.03 0.06 0.91     3.1 
Tyr 
[M-57]
+
 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.10 0.88 2.6 
[M-159
]+
 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.10 0.86  3.1 
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U-
13
C2 Acetate + Glyoxylate 
Amino 
Acid 
TBDMS 
Fragment 
MID 12C
% M0 M1 M2 M3 M4 M5 M6 M7 M8 M9 
Ala 
[M-57]
+
 0.21 0.05 0.32 0.42       35.1 
[M-159]
+
 0.23 0.32 0.44        39.7 
Gly 
[M-57]
+
 0.57 0.06 0.38        59.7 
[M-85]
+
 0.60 0.40         60.2 
Val 
[M-57]
+
 0.09 0.13 0.15 0.19 0.09 0.35     37.9 
[M-159
]+
 0.10 0.25 0.20 0.09 0.36      40.8 
Leu 
[M-15]
+
 0.02 0.09 0.17 0.21 0.11 0.10 0.30    37.1 
[M-159]
+
 0.06 0.19 0.22 0.11 0.08 0.34     40.1 
Ile 
[M-15]
+
 0.05 0.14 0.16 0.16 0.11 0.10 0.27    41.3 
[M-159]
+
 0.07 0.18 0.21 0.14 0.10 0.30     41.3 
Ser 
[M-57]
+
 0.44 0.07 0.07 0.42       50.7 
[M-159
]+
 0.47 0.11 0.42        52.7 
Thr 
[M-57]
+
 0.11 0.13 0.18 0.17 0.41      34.2 
[M-85]
+
 0.13 0.22 0.19 0.46       34.0 
Phe 
[M-57]
+
 0.33 0.11 0.06 0.03 0.01 0.02 0.02 0.03 0.10 0.29 53.5 
[M-159
]+
 0.34 0.13 0.05 0.02 0.02 0.02 0.03 0.09 0.30  53.9 
Asp 
[M-57]
+
 0.10 0.13 0.16 0.14 0.46      31.7 
[M-159
]+
 0.14 0.20 0.18 0.49       32.7 
Glu 
[M-57]
+
 0.04 0.09 0.15 0.15 0.13 0.45     28.1 
[M-159
]+
 0.05 0.12 0.16 0.16 0.51      26.2 
His 
[M-57]
+
 0.15 0.24 0.17 0.03 0.04 0.13 0.25    51.0 
[M-159
]+
 0.15 0.23 0.18 0.06 0.12 0.25     49.5 
Tyr 
[M-57]
+
 0.34 0.13 0.06 0.03 0.01 0.02 0.02 0.03 0.09 0.27 55.8 
[M-159
]+
 0.35 0.14 0.05 0.02 0.02 0.02 0.03 0.09 0.28  55.8 
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1-
13
C Acetate 
Amino 
Acid 
TBDMS 
Fragment 
MID 12C
% M0 M1 M2 M3 M4 M5 M6 M7 M8 M9 
Ala [M-57]
+
 0.40 0.59 0.01 0.00       79.6 
Gly 
[M-57]
+
 0.42 0.59 0.00        70.8 
[M-85]
+
 0.99 0.01         99.3 
Val 
[M-57]
+
 0.39 0.59 0.01 0.00 0.00 0.00     87.4 
[M-159
]+
 0.94 0.04 0.01 0.02 0.00      97.3 
Leu 
[M-15]
+
 0.07 0.70 0.07 0.15 0.02 0.00 0.00  77.3 
[M-159]
+
 0.92 0.06 0.01 0.01 0.00 0.00     97.4 
Ile 
[M-15]
+
 0.09 0.51 0.33 0.05 0.01 0.01 0.00    76.9 
[M-159]
+
 0.38 0.58 0.03 0.00 0.00 0.00     86.9 
Ser 
[M-57]
+
 0.41 0.59 0.00 0.00       80.4 
[M-159
]+
 0.99 0.01 0.00        99.7 
Thr 
[M-57]
+
 0.08 0.60 0.32 0.00 0.00      69.1 
[M-85]
+
 0.35 0.65 0.01 0.00       78.9 
Asp 
[M-57]
+
 0.11 0.61 0.28 0.00 0.00      71.1 
[M-159
]+
 0.40 0.59 0.00 0.00       79.9 
Glu 
[M-57]
+
 0.08 0.46 0.36 0.09 0.01 0.00     70.6 
[M-159
]+
 0.17 0.76 0.06 0.01 0.00      77.8 
His 
[M-57]
+
 0.27 0.50 0.20 0.04 0.00 0.00 0.00    83.1 
[M-159
]+
 0.26 0.49 0.20 0.04 0.00 0.00     86.9 
Tyr 
[M-57]
+
 0.09 0.31 0.41 0.19 0.01 0.00 0.00 0.00 0.00 0.00 81.0 
[M-159
]+
 0.20 0.47 0.29 0.02 0.00 0.00 0.00 0.00 0.00  76.7 
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U-
13
C6 Glucose + Bicarbonate 
Amino 
Acid 
TBDMS 
Fragment 
MID 12C
% M0 M1 M2 M3 M4 M5 M6 M7 M8 M9 
Ala 
[M-57]
+
 0.01 0.00 0.03 0.96       1.9 
[M-159]
+
 0.01 0.04 0.95        3.1 
Gly 
[M-57]
+
 0.01 0.03 0.97        2.1 
[M-85]
+
 0.02 0.98         2.2 
Val 
[M-57]
+
 0.00 0.00 0.00 0.00 0.05 0.95     1.6 
[M-159
]+
 0.00 0.00 0.01 0.05 0.94      2.0 
Leu 
[M-15]
+
 0.00 0.00 0.01 0.03 0.02 0.12 0.83    4.6 
[M-159]
+
 0.00 0.00 0.00 0.01 0.06 0.93     2.1 
Ile 
[M-15]
+
 0.00 0.00 0.01 0.02 0.02 0.16 0.80    4.9 
[M-159]
+
 0.00 0.00 0.00 0.01 0.12 0.86     3.4 
Ser 
[M-57]
+
 0.01 0.00 0.03 0.96       1.7 
[M-159
]+
 0.01 0.02 0.96        2.4 
Thr 
[M-57]
+
 0.01 0.00 0.01 0.11 0.87      4.2 
[M-85]
+
 0.00 0.01 0.10 0.89       4.5 
Phe 
[M-57]
+
 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.07 0.91 1.6 
[M-159
]+
 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.07 0.92  1.6 
Asp 
[M-57]
+
 0.00 0.00 0.01 0.11 0.87      4.1 
[M-159
]+
 0.01 0.01 0.10 0.88       4.5 
Glu 
[M-57]
+
 0.00 0.00 0.00 0.01 0.12 0.86     3.4 
[M-159
]+
 0.00 0.00 0.01 0.04 0.94      2.1 
Tyr 
[M-57]
+
 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.07 0.91 1.6 
[M-159
]+
 0.00 0.00 0.00 0.00 0.00 0.00 0.02 0.07 0.90  2.1 
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U-
13
C6 Glucose + Malate 
Amino 
Acid 
TBDMS 
Fragment 
MID 12C
% M0 M1 M2 M3 M4 M5 M6 M7 M8 M9 
Ala 
[M-57]
+
 0.15 0.02 0.04 0.79       17.5 
[M-159]
+
 0.17 0.05 0.77        19.9 
Gly 
[M-57]
+
 0.15 0.04 0.81        17.1 
[M-85]
+
 0.17 0.83         17.3 
Val 
[M-57]
+
 0.10 0.02 0.04 0.05 0.06 0.73     17.4 
[M-159
]+
 0.10 0.02 0.08 0.07 0.73      17.5 
Leu 
[M-15]
+
 0.10 0.02 0.06 0.07 0.08 0.11 0.56    24.3 
[M-159]
+
 0.12 0.04 0.05 0.06 0.10 0.62     23.6 
Ile 
[M-15]
+
 0.12 0.02 0.12 0.07 0.06 0.14 0.47    29.6 
[M-159]
+
 0.14 0.03 0.11 0.05 0.14 0.53     28.3 
Ser 
[M-57]
+
 0.11 0.03 0.05 0.81       14.8 
[M-159
]+
 0.12 0.06 0.82        15.4 
Thr 
[M-57]
+
 0.22 0.03 0.05 0.12 0.58      29.4 
[M-159
]+
 0.21 0.04 0.15 0.60       28.8 
Phe 
[M-57]
+
 0.02 0.03 0.01 0.02 0.06 0.02 0.05 0.05 0.08 0.67 14.3 
[M-159
]+
 0.02 0.04 0.01 0.02 0.06 0.02 0.08 0.09 0.67  14.0 
Asp 
[M-57]
+
 0.24 0.03 0.05 0.13 0.56      31.4 
[M-159
]+
 0.25 0.05 0.13 0.57       32.8 
Glu 
[M-57]
+
 0.11 0.02 0.10 0.06 0.16 0.55     24.3 
[M-159
]+
 0.10 0.02 0.11 0.09 0.67      20.0 
His 
[M-57]
+
 0.02 0.01 0.04 0.03 0.02 0.14 0.75    9.4 
[M-159
]+
 0.02 0.06 0.05 0.04 0.14 0.75     13.3 
Tyr 
[M-57]
+
 0.02 0.04 0.01 0.02 0.07 0.02 0.05 0.04 0.08 0.66 14.9 
[M-159
]+
 0.02 0.04 0.01 0.02 0.07 0.03 0.08 0.08 0.65  15.0 
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U-
13
C6 Glucose + Yeast Extract 
Amino 
Acid 
TBDMS 
Fragment 
MID 12C
% M0 M1 M2 M3 M4 M5 M6 M7 M8 M9 
Ala 
[M-57]
+
 0.25 0.01 0.03 0.71       26.5 
[M-159]
+
 0.26 0.04 0.71        27.6 
Gly 
[M-57]
+
 0.24 0.03 0.73        25.2 
[M-85]
+
 0.25 0.75         25.0 
Val 
[M-57]
+
 0.33 0.02 0.01 0.02 0.04 0.58     37.3 
[M-159
]+
 0.33 0.02 0.03 0.05 0.57      37.1 
Leu 
[M-15]
+
 0.42 0.03 0.09 0.16 0.04 0.05 0.23    59.5 
[M-159]
+
 0.54 0.08 0.01 0.02 0.03 0.32     62.6 
Ile 
[M-15]
+
 0.50 0.03 0.11 0.14 0.02 0.05 0.15    68.1 
[M-159]
+
 0.61 0.04 0.11 0.02 0.04 0.18     72.1 
Ser 
[M-57]
+
 0.13 0.03 0.05 0.79       16.8 
[M-159
]+
 0.14 0.07 0.79        17.4 
Thr 
[M-57]
+
 0.27 0.02 0.02 0.12 0.56      33.0 
[M-159
]+
 0.27 0.04 0.12 0.58       33.1 
Phe 
[M-57]
+
 0.61 0.05 0.00 0.00 0.00 0.00 0.01 0.01 0.03 0.29 66.0 
[M-159
]+
 0.61 0.05 0.01 0.00 0.00 0.00 0.01 0.03 0.29  66.7 
Asp 
[M-57]
+
 0.06 0.01 0.03 0.15 0.74      12.3 
[M-159
]+
 0.06 0.03 0.15 0.76       13.2 
Glu 
[M-57]
+
 0.05 0.01 0.03 0.05 0.17 0.69     13.4 
[M-159
]+
 0.05 0.01 0.06 0.08 0.81      10.5 
His 
[M-57]
+
 0.10 0.01 0.01 0.01 0.02 0.18 0.67    15.4 
[M-159
]+
 0.12 0.00 0.01 0.04 0.17 0.67     17.1 
Tyr 
[M-57]
+
 0.34 0.03 0.00 0.00 0.00 0.00 0.02 0.02 0.06 0.53 38.6 
[M-159
]+
 0.34 0.03 0.01 0.00 0.01 0.01 0.03 0.05 0.53  38.8 
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U-
13
C6 Glucose (5 g/L) + Phenol (0.5 g/L) 
Amino 
Acid 
TBDMS 
Fragment 
MID 12C
% M0 M1 M2 M3 M4 M5 M6 M7 M8 M9 
Ala 
[M-57]
+
 0.24 0.08 0.08 0.60       32.2 
[M-159]
+
 0.26 0.13 0.61        32.4 
Gly 
[M-57]
+
 0.30 0.07 0.63        33.4 
[M-85]
+
 0.33 0.67         33.3 
Val 
[M-57]
+
 0.08 0.06 0.16 0.19 0.12 0.39     32.5 
[M-159
]+
 0.08 0.07 0.30 0.16 0.39      32.5 
Leu 
[M-15]
+
 0.05 0.05 0.20 0.19 0.28 0.09 0.14    42.6 
[M-159]
+
 0.06 0.07 0.22 0.20 0.27 0.19     37.7 
Ile 
[M-15]
+
 0.14 0.10 0.33 0.18 0.11 0.10 0.05    58.4 
[M-159]
+
 0.15 0.11 0.38 0.16 0.14 0.06     55.7 
Ser 
[M-57]
+
 0.19 0.11 0.11 0.59       30.0 
[M-159
]+
 0.23 0.18 0.58        32.5 
Thr 
[M-57]
+
 0.47 0.15 0.17 0.13 0.08      70.6 
[M-159
]+
 0.52 0.21 0.19 0.09       71.8 
Phe 
[M-57]
+
 0.01 0.01 0.01 0.02 0.12 0.10 0.19 0.18 0.11 0.24 27.2 
[M-159
]+
 0.01 0.01 0.01 0.04 0.13 0.12 0.29 0.14 0.24  25.3 
Asp 
[M-57]
+
 0.49 0.14 0.17 0.12 0.08      71.0 
[M-159
]+
 0.53 0.19 0.19 0.10       71.3 
Glu 
[M-57]
+
 0.27 0.12 0.25 0.12 0.13 0.12     58.3 
[M-159
]+
 0.29 0.15 0.25 0.12 0.19      55.7 
Tyr 
[M-57]
+
 0.01 0.01 0.01 0.03 0.12 0.10 0.18 0.19 0.12 0.24 27.3 
[M-159
]+
 0.01 0.01 0.02 0.04 0.14 0.12 0.28 0.14 0.24  25.8 
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U-
13
C6 Glucose (1 g/L) + Phenol (0.5 g/L) 
Amino 
Acid 
TBDMS 
Fragment 
MID 12C
% M0 M1 M2 M3 M4 M5 M6 M7 M8 M9 
Ala 
[M-57]
+
 0.21 0.08 0.08 0.63       29.1 
[M-159]
+
 0.23 0.13 0.64        29.5 
Gly 
[M-57]
+
 0.28 0.07 0.65        31.2 
[M-85]
+
 0.30 0.70         30.2 
Val 
[M-57]
+
 0.05 0.05 0.16 0.19 0.13 0.41     29.1 
[M-159
]+
 0.06 0.06 0.29 0.17 0.41      29.5 
Leu 
[M-15]
+
 0.03 0.03 0.16 0.27 0.29 0.09 0.12    41.6 
[M-159]
+
 0.04 0.05 0.19 0.22 0.30 0.20     34.1 
Ile 
[M-15]
+
 0.09 0.08 0.31 0.27 0.14 0.08 0.04    55.1 
[M-159]
+
 0.11 0.11 0.38 0.18 0.16 0.07     52.7 
Ser 
[M-57]
+
 0.18 0.10 0.12 0.60       28.5 
[M-159
]+
 0.22 0.16 0.62        30.0 
Thr 
[M-57]
+
 0.45 0.11 0.23 0.16 0.05      68.5 
[M-159
]+
 0.47 0.26 0.19 0.08       71.0 
Phe 
[M-57]
+
 0.01 0.01 0.01 0.02 0.08 0.10 0.19 0.20 0.13 0.26 24.4 
[M-159
]+
 0.01 0.01 0.01 0.03 0.10 0.11 0.29 0.17 0.27  23.5 
Asp 
[M-57]
+
 0.45 0.15 0.19 0.14 0.08      69.1 
[M-159
]+
 0.50 0.20 0.21 0.09       70.3 
Glu 
[M-57]
+
 0.28 0.15 0.30 0.14 0.09 0.04     65.0 
[M-159
]+
 0.29 0.18 0.32 0.13 0.07      62.1 
Tyr 
[M-57]
+
 0.01 0.01 0.01 0.02 0.09 0.11 0.19 0.18 0.13 0.25 25.2 
[M-159
]+
 0.01 0.01 0.01 0.04 0.11 0.13 0.26 0.18 0.25  24.7 
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4 Chapter Four: Characterizing and Re-wiring of Metabolic 
Pathways in Cyanobacteria 
The work presented has been partially reported in the following publications: 
Abernathy, M.H., Yu, J., Ma, F., Liberton, M., Ungerer, J., Hollinshead, W., Gopalakrishnan, S., He, L., 
Maranas, C., Pakrasi, H.B., Allen, D.K., & Tang, Y.J. Deciphering phenotypes for fast photoautotrophic 
growth in Synechococcus elongatus UTEX 2973.[Submitted] (I contributed to the transient 
13
C-labeling 
experiments ). 
 
Wan, N., DeLorenzo, D.M., He, L., You, L., Immethun, C., Wang, G., Baidoo, E.E.K., Hollinshead, 
W.D., Keasling, J.D., Moon, T.S., & Tang, Y.J. Cyanobacterial carbon metabolism: fluxome plasticity 
and oxygen dependence. [Submitted] (I contributed to 
13
C-labeling experiments on Synechocystis 6803 
and its EDP mutants). 
Abstract 
While Synechococcus elongatus UTEX 2973 and Synechococcus elongatus 7942 have a 99.8% 
genetic similarity, they have significantly different growth rates at optimal conditions. The 
fluxome of the faster-growing cyanobacterium, Synechococcus elongatus UTEX 2973, and its 
close relative, Synechococcus elongatus 7942, were elucidated through isotopically non-
stationary 
13
C-Metabolic Flux Analysis.  The results showed higher flux through carbon 
assimilatory and photorespiratory pathways were highlighted in S. elongatus 2973 as compared 
to S. elongatus 7942. In addition, the resulting flux map revealed key metabolic differences 
between these strains and model cyanobacterium, Synechocystis PCC 6803, which suggested a 
novel metabolic engineering strategy for improved growth.  The engineering strategy was to 
replace the carbon inefficient pathways with a heterologous Entner-Doudoroff (ED) pathway in 
Synechocystis 6803. However, the engineered strains failed to show improvements in growth or 
enhanced activity of EDP under dark conditions. These results confirm that Synechocystis. 6803 
oxidative pentose phosphate pathway and its other carbon-regenerating pathways are robust and 
important for the strain’s growth.  
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4.1 Introduction 
The main roadblocks preventing cyanobacteria’s ability to compete with other microbial 
platforms is its slow growth and heavy dependence on light acquisition. A novel cyanobacterium, 
S. elongatus 2973, has been isolated with doubling times as high as 1.9 hours, growing as fast as 
the industrial host, Saccharomyces cerevisiae (Yu et al. 2015). This new strain has the possibility 
to alleviate the problems associated with cyanobacteria fermentation. In comparison to 
Saccharomyces cerevisiae, cyanobacteria offer many advantages beneficial for advanced biofuel 
production. They are robust, require minimal nutrients, and capable of CO2 fixation (Yu et al. 
2013). Therefore, S. elongatus 2973 is a very promising cyanobacterial chassis for improving 
cyanobacterial biofuel production. To further understand the metabolic phenotype behind its fast 
growth, we conducted isotopically non-stationary 
13
C-Metabolic Flux Analysis (
13
C-MFA). 
Unlike most heterotrophic metabolisms, which can form unique isotope distributions based 
on their flux profile, 
13
C-MFA on autotrophic (C1) metabolism requires measuring the rate of 
isotopic enrichment to delineate the fluxes of the central metabolism (Nöh et al. 2007; Young et 
al. 2011).  Currently, only model cyanobacterium’s, Synechocystis PCC 6803, flux map has been 
elucidated (Xiong et al. 2015; Young et al. 2011). These studies have identified a relatively 
powerful oxidative pentose phosphate pathway (OPPP) under heterotrophic conditions (You et al. 
2014), which is surprisingly still active ( ~15%) during autotrophic growth. In addition, the malic 
enzyme had small but significant flux and was an important source of pyruvate for the cell 
(Young et al. 2011).  These features were prominent differences between S. elongatus 2973 and 
Synechocystis 6803 autotrophic metabolisms. Thus, we re-wired Synechocystis 6803 metabolism 
to use Entner-Doudoroff pathway (EDP) as a direct source of pyruvate and an alternative 
pathway to the inefficient OPPP. 
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4.2 Results and Discussion 
4.2.1 13C-MFA of 2973 
S. elongatus 2973 and S. elongatus 7942 were both grown in a high-light photobioreactor 
to early exponential phase, and then pulsed with NaH
13
CO2. The rate of labeling in the 
metabolites was measured by quenching (a rapid halting of the metabolism) of the culture to 
capture the labeling distribution at specific time points. Initially, we followed the traditional 
method of quenching the metabolites with cold methanol then extracting using a methanol-
chloroform protocol. As methanol can be cooled to -70
O
C, it works well to rapidly cool the 
culture. However, methanol is also the extraction solvent, and often the methanol quenching 
solution will cause significant metabolite leakage.  
Thus, we developed a quenching method using liquid nitrogen as the coolant that allowed 
cultures to quickly drop to low temperatures (~ 4
O
C) without loss of metabolites. The method 
consists of using a small canister that allows your culture tube to sit in liquid nitrogen while 
constantly agitating the culture to prevent freezing. Use of a thermometer to measure the 
temperature change showed that this method can rapidly cooled cultures. This provided us with 
much better LC-MS data, allowing us to capture the labeling dynamics of key metabolites.  The 
publically available INCA software was used to generate the flux map shown in Figure 
4.1(Young 2014).  
While the overall CO2 uptake between the two Synechococcus strains gave different 
absolute fluxes (not shown), once normalized, a clear view of the differences in metabolic 
topology between the two strains are shown.  S. elongatus 2973 has higher relative flux through 
fructose-biphosphate aldolase (FBP->F6P) while S. elongatus 7942 has higher fluxes through 
transketolase reactions. Interestingly, S. elongatus 2973 showed no flux through the malic 
enzyme while S. elongatus 7942 maintained a small flux. In addition, the decreased flux towards 
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G6P from F6P agrees with the lower demand of glycogen in the faster growing cyanobacterium 
(Yu et al. 2015). The major flux differences between these optimal cyanobacterial metabolisms 
and the previously reported flux distribution of Synechocystis 6803 were in the removal of CO2 
draining reactions: malic enzyme and 6-phosphogluconate dehydrogenase. These variances, 
while important for Synechocystis 6803 capacity to grow in various light and dark conditions, 
may be limiting its optimal growth rate. 
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Figure 4.1 Synechococcus elongatus 2973 Flux Map 
Normalized (to net uptake of 100 mol CO2). Fluxes on the top are from S. elongatus 2973 and 
fluxes on the bottom are produced from S. elongatus 7942. Dotted lines represented pathways 
with enzymes that are not annotated for Synechococcus elongatus on the KEGG Genome 
database. Abernathy et al., Manuscript Submitted 
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4.2.2 Reprogramming Synechocystis PCC 6803  
While the growth rate of Synechocystis 6803 cannot compete with either S. elongatus 
2973 or S. elongatus 7942, the strain is still favorable due to its excellent photomixotrophic 
capabilities. Industrial cyanobacterial bioprocesses benefit from microbial hosts that can utilize 
light and CO2 when sufficiently available and glucose under low light and CO2 conditions, 
typical of environments in large photobioreactors or sun-lit reactors. Thus, the lack of flux 
through OPPP and malic enzyme in S. elongatus 2973 suggested that these may be beneficial 
targets for engineering Syn. 6803 to be a faster-growing photomixotrophic strain. As an 
alternative to the OPPP, EDP is a glycolytic pathway that would (1) provide NADPH without 
generating CO2, (2) provide pyruvate (and one glyceraldehyde 3-phosphate) which would reduce 
the need for the malic enzyme and (3) only require two additional enzymes: 6PG dehydratase 
(edd) and 2-keto-3-deoxyphosphogluconate (KDPG) aldolase (eda), to complete the pathway. 
Heterologous pathways (edd and eda) from R. opacus PD630 and E. coli were introduced into 
6803 via a replicative plasmid (RSF1010 replicon).  Two promoters were used: the arabinose-
inducing pBAD promoter and constitutive pTrc promoter.  
Despite verification by RT-PCR, the engineered strains failed to show EDP activity using 
our 1-
13
C glucose fingerprinting assay. For the EDP assay, the cells were grown under light-
activated dark conditions with 1-
13
C glucose and the resulting labeling distribution of alanine 
(pyruvate-derived) were measured. If EDP is active then the m+0 of the [M-85]
+
 fragment would 
be higher than the m+0 of the [M-57]
+
 fragment. As shown in Table 4.1, there is little to no 
differences between the two fragments suggesting that glucose is almost exclusively being 
degraded by OPPP in the dark condition.  
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Table 4.1 Mass Isotopomer Distribution of Alanine (Pyruvate-derived) for Engineered 
Strains 
 6803 pBAD-ED(roa) pTrc-ED(eco) Δgnd* 
Alanine     
m-57     
m+0 0.96 0.96 0.95 0.98 
m+1 0.04 0.04 0.05 0.02 
m+2 0.00 0.00 0.00 0.00 
m+3 0.00 0.00 0.00 0.00 
m-85     
m+0 0.97 0.98 0.95 0.98 
m+1 0.03 0.02 0.05 0.02 
m+2 0.00 0.00 0.00 0.00 
Technical standard deviation is 0.02. 
 * Δgnd did not grow under the dark conditions, thus the biomass is almost fully unlabeled. 
*Residual 
12
C from NaHCO3 and glucose from the seed cultures may have minor influences on 
distribution and thus this is only a qualitative assay on presence of EDP.   
A previous study of the photoheterotrophic fluxome of 6803 has already revealed OPPP as 
the major catabolic pathway for glucose (You et al. 2015). It is possible that the native 
infrastructure of OPPP in 6803 cells is so robust that the engineered EDP could not compete. 
Therefore, we disrupted OPPP by removing gnd from the genome and overexpressed EDP, this 
strain showed significantly impaired growth under dark conditions, and thus we were unable to 
get reliable data on EDP activity (Table 4.1 & Fig. 4.2).  
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Figure 4.2 Growth Profile of ED-expressing (from R. opacus) 6803 strains 
However, when the strains were supplied with ~50 μE/m2/s for photomixotrophic growth, 
the over-expression of ED pathway in Δgnd strains improved growth compared to their wild type 
counterparts (WT with ED plasmid) (Table 4.2).  Unfortunately, while 1-
13
C glucose 
fingerprinting is an accurate tool when 6803 is forced to exclusively used their heterotrophic 
metabolism, under light conditions the qualitative assay would fail to provide useful data due to 
the uptake of CO2 and carbon re-cycling through the calvin cycle.  Therefore, it is unclear if EDP 
is active under photomixotrophic conditions, but gnd deletion does appear to recover the cell’s 
growth from any metabolic burden effects.  
Table 4.2 Engineered strains growth rates under light and dark conditions 
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In addition, the knockout of gnd in 6803 resulted in an altered color of the supernatant. The 
dark brown color was consistently produced in both strains with only gnd deletion and Δgnd 
strains overexpressing the ED pathway. It is suspected the knockout would cause possible 
accumulation of 6PG and reduced NADPH supply under dark conditions; it appears that this may 
have a global effect on the cell metabolism. Suspecting that the color was due to a build-up of 
pterine compounds, we added sodium diothionite, which would break the aromatic core and 
result in a color change. Figure 4.3 shows our confirmation via a sodium diothionite treatment, 
that the Δgnd strains secrete pterine-like compounds.  
 
Figure 4.3 ∆gnd supernatant. 
A) Supernatant from wild type (left) and ∆gnd (right) strains after 7 days of growth at ~100 
µE/m 2 /s. ∆gnd produces a compound(s) that darkens the supernatant to a reddish-brown color. 
To test whether the compound may be a class of pterine molecule, the sodium diothionite was 
added(thought to cause a reduction/possible removal of the pterine’s aromatic core and evidence 
by a color change). B) Untreated supernatant from ∆gnd (left) and ∆gnd supernatant treated with 
sodium dithionite (right). Wan et al., Unpublished 
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4.3 Conclusion and Future Work 
Currently, Synechococcus elongatus 2973 is the fastest-growing cyanobacterium reported, 
its flux map presents a topology that is optimized for autotrophic growth. Major differences 
between the strain flux distribution and flux maps previously reported for Synechocystis 6803 
sparked a novel engineering strategy to introduce a working Entner-Doudoroff pathway to 
reduce fluxes through the oxidative pentose pathway and malic enzyme. However, our study 
confirmed that heterologous expression of pathways may fail in Synechocystis 6803, possibly 
due to misfolding, photosynthesis-dependence or other unknown problems.  
Despite the confirmation of RNA production of the EDP enzymes, our assay failed to 
detect significant EDP flux and the overexpression appeared to inhibit its growth in gnd 
knockouts. With the lack of clear results on EDP activity in cyanobacteria, there is still interest in 
reviewing whether the EDP enzymes are being expressed. With further work using proteomics 
and metabolomics, we could create a clearer picture that could explain the little to no EDP 
activity we detect in our strains.  Recently, a new study has suggested the presence and activity 
of a native EDP in Synechocystis 6803 through a series of knockout experiments, thus another 
approach would be alternatively overexpressed these native genes for better EDP expression 
(Chen et al. 2016). In addition, Synechococcus elongatus 2973 has enormous potential to 
improve cyanobacterial productions, and moving towards utilizing this strain for commodity 
products may provide a low cost-high profit bio-based production. 
4.4 Methods 
4.4.1 Cultivation for transient labeling experiments.  
All cultures used were grown on BG-11 medium lacking citrate (pH 8.0-8.5) at 38 ºC. A 8-test 
tube (max cap. 85 mL) multi-cultivator system (MC 1000, Photon Systems Instruments, Czech 
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Republic) with a working volume of 40 mL provided cells with 3% CO2 aeration (2000 mL/min) 
and 500 μmol photons•m-2•s-1 for isotopic labeling experiments. Except Synechococcus 7942 was 
grown under 300 μmol photons•m-2•s-1. Fresh cells were inoculated in PBR (3% inoculation 
ratio). Seed cultures were grown in 125 mL-shaking flasks open to atmospheric CO2, at 38 ºC, 
250 rpm and 100 μmol photons•m-2•s-1. For the labeling experiment, a 2 mL aliquot of 
NaH
13
CO3 (Sigma Aldrich, St Louis) was injected into each PBR during exponential phase for a 
final concentration of 4 g/L of NaH13CO3. Each test tube of culture in the PBR was quenched at 
different time intervals after the 
13
C-pulse ranging from 20 seconds to 2 hours.  
4.4.2  Metabolite extraction and analysis.  
A liquid N2 bath was used to quench the metabolism. Briefly, 50mL centrifuge tubes containing 
10 mL BG-11 medium (no carbon) were placed in liquid N2 to pre-chill the media. Then cultures 
after 
13
C-pulse were quickly poured into centrifuge tubes submerged in a liquid N2 bath. Once 
temperature dropped below 4
o
C, samples were then centrifuged at ~0 °C. The pellets were mixed 
with 7:3 methanol: chloroform extraction solution and shaked overnight at 4
o
C. Samples were 
then freeze-dried and stored at -80
O
C until LC-MS analysis.  Ion-pairing LC-MS/MS was 
performed at the Proteomics and Mass Spectrometry Facility, Donald Danforth Plant Science 
Center, St. Louis, MO. The labeling of organic acids were quantified using hydrophilic 
interaction liquid chromatography (HILIC) coupled to electrospray time-of-flight MS at Joint 
Bio-Energy Institute, CA. Flux calculations based on the 
13
C transient labeling results were 
modeled using INCA(Young 2014).   
4.4.3 Strain construction.   
Enzymes were purchased from New England BioLabs, Inc (Ipswich, MA) and oligonucleotides 
were purchased from Integrated DNA Technologies (Coralville, IA). The EDP operon from R. 
opacus (g6pdh, edd, eda) and EDP genes from E. coli (edd, eda) were amplified via PCR. 
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Plasmids were developed using the Golden Gate assembly protocol. Antibiotic concentrations 
used were the following: spectinomycin (100 µg/mL), gentamycin (10 µg/mL), and 
chloramphenicol (34 µg/mL. The developed plasmids were transformed into Synechocystis 6803, 
the protocol further detailed in published study(Immethun et al. 2016). Plasmid transformations 
were confirmed via colony PCR. Double homologous recombination was used to knockout gnd. 
EDP mutants (from E. coli) were tested using reverse transcription PCR (RT-PCR).  
4.4.4 Cultivation conditions for EDP engineered strains.  
For media preparation, all chemicals were purchased from Sigma Aldrich (Saint Louis, MO, 
USA). Cells were grown in BG-11 medium at 30°C under light-activated dark condition (~30 
minute light pulse per day) in approximately ~25 mL cultures in 250 mL Erlenmeyer flasks. 
pBAD-ED(roa) and Δgnd were grown with 1 g/L of 1-13C glucose, while pTrc-ED(eco) and 
6803 were grown with 2 g/L of 1-
13
C glucose. Antibiotics were added as needed. Seed culture 
(EDP mutants) were grown in the light and supplemented with 5 mM glucose, 2 g/L NaHCO3, 
and if necessary 5 mM sodium pyruvate, 0.2 g/L malate and 100 mM arabinose for induction. 
All cultures were started at an initial OD730 of 0.4. The final ODs at time of harvesting were 
2.237, 1.115, 3.634, 0.422 (in the order as they appear in the table 4.1).  
4.4.5 Isotopomer analysis of proteinogenic amino acids.  
The incorporation of labeled carbon into proteinogenic amino acids was measured by GC-MS 
(Hewlett-Packard model 7890A, Agilent Technologies). Biomass pellets were hydrolyzed by 6 
M HCl at 100°C. The resulting mixtures were subsequently air-dried and derivatized with N-tert-
butyldimethylsilylN-methyltrifluoroacetamide (TBDMS) prior to GC-MS analysis(You et al. 
2012).  The amino acid MS data ( [M-57]
+
 and [M-85] +) were corrected for natural isotopic 
abunadance using the following published software (Wahl et al. 2004b). Isotopomer labeling 
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fractions (m+0, m+1, m+2, etc.) represent fragments containing unlabeled, singly labeled, doubly 
labeled amino acids, and so on.  
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5 Chapter Five: Examining Escherichia coli glycolytic pathways, 
catabolite repression, and metabolite channeling using Δpfk 
mutants 
This chapter has been reproduced from the following publication: 
Hollinshead, W.D., Rodriguez, S., Martin, H.G., Wang, G., Baidoo, E.E., Sale, K.L., Keasling, J.D., 
Mukhopadhyay, A., & Tang, Y.J. Examing Escherichia coli glycolytic pathways, catabolite repression, 
and metabolite channeling using Δpfk mutants. Biotechnology for Biofuels. 9:212 (2016) (I contributed to 
pathway engineering, and analysis of mutant strains). 
Abstract 
Glycolysis breakdowns glucose into essential building blocks and ATP/NAD(P)H for the cell, 
occupying a central role in its growth and bio-production. Among glycolytic pathways, the 
Entner Doudoroff pathway (EDP) is a more thermodynamically favorable pathway with fewer 
enzymatic steps than either the Embden-Meyerhof-Parnas pathway (EMPP) or the oxidative 
pentose phosphate pathway (OPPP). However, Escherichia coli do not use their native EDP for 
glucose metabolism. In this s study, overexpression of edd and eda in E. coli to enhance EDP 
activity resulted in only a small shift in the flux directed through the EDP (~20 % of glycolysis 
flux). Disrupting the EMPP by phosphofructokinase I (pfkA) knockout increased flux through 
OPPP (~60 % of glycolysis flux) and the native EDP (~14 % of glycolysis flux), while 
overexpressing edd and eda in this ΔpfkA mutant directed ~70 % of glycolytic flux through the 
EDP. The downregulation of EMPP via the pfkA deletion significantly decreased the growth rate, 
while EDP overexpression in the ΔpfkA mutant failed to improve its growth rates due to 
metabolic burden. However, the reorganization of E. coli glycolytic strategies did reduce glucose 
catabolite repression. The ΔpfkA mutant in glucose medium was able to cometabolize acetate via 
the citric acid cycle and gluconeogenesis, while EDP overexpression in the ΔpfkA mutant 
repressed acetate flux toward gluconeogenesis. Moreover, 
13
C-pulse experiments in the 
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ΔpfkA mutants showed unsequential labeling dynamics in glycolysis intermediates, possibly 
suggesting metabolite channeling (metabolites in glycolysis are pass from enzyme to enzyme 
without fully equilibrating within the cytosol medium). In conclusion, we engineered E. coli to 
redistribute its native glycolytic flux. The replacement of EMPP by EDP did not improve E. coli 
glucose utilization or biomass growth, but alleviated catabolite repression. More importantly, our 
results supported the hypothesis of channeling in the glycolytic pathways, a potentially 
overlooked mechanism for regulating glucose catabolism and coutilization of other substrates. 
The presence of channeling in native pathways, if proven true, would affect synthetic biology 
applications and metabolic modeling. 
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5.1 Background 
E. coli has three native glycolytic pathways: EMPP, EDP, and OPPP. The EMPP 
employs ten enzymatic steps to yield two pyruvate,  two ATP, and two NADH per glucose 
molecule (Romano and Conway 1996), while OPPP serves as an oxidation route for NADPH 
synthesis. In E. coli, glucose metabolism mainly relies on the EMPP and the OPPP, while the 
EDP primarily remains inactive except during growth with gluconate (Eisenberg and Dobrogosz 
1967). The EDP utilizes only five enzymes to produce one pyruvate, one glyceraldhyde-3-
phosphate, and one NADPH per glucose molecule (Fig. 5.1). With further conversion of 
glyceraldhyde-3-phosphate via the lower EMPP, the two pathways (EDP and EMPP) result in 
the same net production of pyruvate. However, the EMPP contains thermodynamic bottlenecks, 
comprising of fructose 1,6-bisphosphate aldolase and triose-phosphate isomerase. The EDP 
avoids both these unfavorable reactions (at the expense of ATP yield), and requires substantially 
less enzymatic protein than the EMPP (Flamholz et al. 2013). Its end-products (glyceraldehyde 
3-phosphate and pyruvate) are precursors of the non-mevalonate pathway and thus EDP 
upregulation has been proven to improve the yields of isoprenoids (Li et al. 2015; Liu et al. 
2014; Ng et al. 2015). In addition, the EDP may also alleviate oxidative stress (Chavarría et al. 
2013; Klingner et al. 2015) and improve NADPH generation without the loss of carbon (i.e., 
CO2) (He et al. 2014).  
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Figure 5.1 Redistribution of fluxes between the three primary glucose catabolic pathways 
Redistribution of fluxes between the three primary glucose catabolic pathways: EMPP (red), 
EDP (blue), and OPPP (orange) via the knockout of pfkA and overexpression of EDP genes (edd 
and eda). Table on the right presents the estimated flux ratio between the three pathways for each 
strain. The dashed arrows represent a possible interference (unannotated) source from glycogen 
metabolism (Long et al. 2016).  
The EDP relies on two unique enzymes phosphogluconate dehydratase (edd) and 2-
dehydro-3-deoxyphosphogluconate aldolase (eda), which are separate from the enzymes shared 
with the EMPP and OPPP. In wild type (WT) E. coli, EDP flux is negligible. Δpgi (G6PF6P, 
encoding glucose-6-phosphate isomerase), Δpfk (F6PFBP, encoding phosphofructokinase), or 
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overexpression of OPPP may redirect glycolytic fluxes and increase EDP activity (Seol et al. 
2016; Toya et al. 2010). Δpgi mutant has measureable EDP flux (up to ~15% of glycolysis), but 
grew and consumed glucose more slowly than the WT strain. Δpgi mutant may recover its 
growth rate by either increasing acetate overflow or activating the glyoxylate shunt after adaptive 
evolution (Fong et al. 2006). Moreover, some bacterial species with exclusive EDP activity (e.g., 
Rhodococcus opacus) can co-utilize glucose with other substrates (Hollinshead et al. 2016). 
Thus, we were curious if the presence of a highly active EDP could alleviate E. coli glucose 
catabolite repression and promote cell growth. To re-organize the glycolytic pathways, we 
engineered and characterized ΔpfkA mutants (deletion of phosphofructokinase I, important in the 
regulation of glycolysis-gluconeogenesis, Fig. 5.1). Through growth experiments and 
13
C- 
labeling, we elucidated E. coli physiological changes and its capability for simultaneous 
utilization of carbon substrates. Finally, ΔpfkA mutants also allowed us to evaluate the 
hypothesis of the existence of metabolite channeling in glycolytic pathways (Shearer et al. 2005).  
5.2 Results  
5.2.1 Overexpression of EDP in E. coli 
Overexpressing edd and eda in the wild type (WT) strain reduced the flux (~20%) 
through EMPP and OPPP. Despite the increased EDP activity, the growth rate of the EDP 
overexpressing strain decreased by ~30% compared to WT (Table 5.1). To confirm the tradeoff 
from metabolic burdens imposed by antibiotics and plasmid/protein expression, we replaced 
EDP genes with the gene encoding for yellow fluorescent protein (YFP). The YFP-expressing 
strain had a similar reduced growth. A recent study found that the insertion of EDP (pgi, zwf, pgl, 
edd, eda from Z. mobilis) into E. coli chromosome also repressed the growth of the engineered 
strain(Ng et al. 2015a).  
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Table 5.1 Strains/Plasmids Used 
Plasmids/ 
Strains 
Description Maximal 
Growth 
Rate (h
-1
) 
JBEI  
ICE 
Codes 
Source 
 Plasmids 
  pBbE5c-YFP Backbone vector expressing YFP - - (Lee et al. 
2011) 
  Pedw Derived from pBbE5c-YFP with gene 
replaced by edd and eda 
- - This study 
 Strains 
BW25113 Keio collection WT(rrnB3 ∆lacZ4787 
hsdR514 ∆araBAD567 ∆rhaBAD568 rph-1 ) 
0.78±0.02 - (Baba et al. 
2006) 
 JW3887 BW25113 ∆pfkA 0.18±0.02 - 
WH01 BW25113 (pBbE5c-YFP) 0.56±0.07 JBEI-
14575 
This study 
WH02 JW3887 (pBbE5c-YFP) 0.13±0.01 JBEI-
14585 
This study 
WH03 BW25113 (pEDW) 0.49±0.02 JBEI-
11465 
This study 
WH04 JW3887 (pEDW) 0.18±0.01 JBEI-
11468 
This study 
 
To further improve EDP flux, the Keio collection ΔpfkA (phosphofructokinase I, 
F6PFBP) mutant was used (Baba et al. 2006). The phosphofructokinase has two isoenzymes 
(pfkA and pfkB) with pfkA as the primary enzyme responsible for the conversion of F6P to FBP 
(Fraenkel 1986). 
13
C-fingerprinting revealed that the ΔpfkA mutant (JW3887) distributed glucose 
flux through the OPPP (~62%), the EDP (~14%) and the EMPP (~24%) (Fig. 5.1). The pfkA 
knockout increased cell lag phase, and reduced both cell growth rate and acetate overflow 
(Supporting Fig. S5.1). This is because the glycolytic flux reorganization can cause metabolic 
burdens, cofactor imbalances, and reduced carbon yield due to CO2 loss from the high OPPP flux 
(Seol et al. 2014). Overexpressing EDP in the ΔpfkA mutant (resulting in strain WH04) raised the 
EDP flux to ~72% and reduced the EMPP flux to ~18% (Fig. 5.1). WH04 grew much faster than 
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WH02 (the ∆pfkA mutant with YFP overexpression) (Table 5.1), indicating a beneficial impact 
of EDP in the absence of EMPP.  
5.2.2  Removal of Glucose Carbon Catabolite Repression  
Lignocellulose hydrolysate contains glucose, xylose and acetate. However, carbon 
catabolite repression (CCR) inhibits hosts from consuming diverse substrates simultaneously 
(i.e., E. coli mainly consumes glucose in a glucose/xylose medium). The CCR is often explained 
by glucose inhibition on the synthesis of enzymes involved in catabolism of other carbon 
sources, while recent studies suggest the presence of subpopulations within E. coli cultures can 
have different carbon utilization hierarchies (Beisel and Afroz 2016; Koirala et al. 2016). To 
investigate glucose catabolite repression, we grew the strains with a mixed carbon source of 10 
g/L of glucose and 6 g/L of xylose, and measured the consumption of the two sugars (Fig. 5.2A 
and Fig. 5.2B). The ΔpfkA mutant (JW3887) simultaneously consumed glucose and xylose, and 
xylose co-utilization nearly doubled the growth rate compared to its glucose-only culture (Fig. 
5.2A). WH04 can also uptake xylose with glucose, and xylose addition reduced the strain’s lag 
phase (Fig. 5.2B). Moreover, the assimilation of xylose into biomass was determined through 
13C-experiments (cultures fed with 
13C6-glucose and unlabeled xylose). The fraction of xylose 
incorporated into proteinogenic amino acids during the exponential phase was measured (Fig. 
5.2C). For both JW3887 and WH04, the xylose incorporation was ~50% (Fig. 5.2C), much 
higher utilization than in the WT strain. Therefore, the removal of one pivotal EMP enzyme, 
phosphofructokinase I, alleviated glucose catabolite repression.   
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Figure 5.2 Glucose and xylose co-utilization 
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Profile of growth (open square), acetate production (star), and consumption of glucose (open 
circle) and xylose (open triangle) in mutant strains: a. ∆pfkA mutant (JW3887) and b. WH04 
grown with glucose and xylose. OD600 of cultures grown solely with glucose are also shown 
(closed circles). c 
13
C isotopic labeling tracing in cultivations fed 10 g/L of 
13
C6-glucose and 
6 g/L of unlabeled xylose. Xylose contribution (fraction of 
12
C) in proteinogenic amino acids is 
graphed for the three strains (2 % isotopic measurement errors were applied) (n = 2). 
 
Acetate, another common component in lignocellulosic hydrolysate, has to be 
metabolized through gluconeogenesis (Zhao and Shimizu 2003a). ΔpfkA is expected to alleviate 
the EMPP repression on gluconeogenesis, and improve the co-utilization of glucose and acetate. 
To test this hypothesis, the mutants (JW3887 and WH04) were grown with 10 g/L of glucose and 
supplemented with 6 g/L of sodium acetate during the early exponential phase (Fig. 5.3A, 5.3B 
and 5.3C). Although acetate may interfere with intracellular pH and hinder E. coli growth (Luli 
and Strohl 1990; Xiao et al. 2013), JW3887 was able to co-utilize acetate with little effect on its 
growth. Acetate incorporation into biomass measured via cultures fed with unlabeled glucose 
and fully labeled acetate revealed that the mutant utilized acetate for biomass synthesis with 
significant incorporation of 
13
C into TCA and glycolysis-derived proteinogenic amino acids (Fig. 
5.3D). In contrast, the glycolytic amino acids: Ala, Phe, and Ser were unlabeled in WT under 
similar mixed carbon cultures, these amino acids being derived from PYR, PEP, and 3PG, 
respectively. Therefore, ΔpfkA (JW3887) could co-utilize acetate to generate TCA cycle 
metabolites and glycolytic intermediates via up-regulation of gluconeogenesis. However, 
introduction of EDP into the ΔpfkA mutant inhibited gluconeogenesis, as revealed with a lack of 
13
C Ala/Phe/Ser in WH04 biomass (Fig. 5.3D).  
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Figure 5.3 Glucose and acetate co-utilization 
 
 
The growth (open square) and substrate consumption (glucose, open circle; acetate, open 
triangle) in mutant strains initially fed 10 g/L of glucose then supplemented with 6 g/L of 
sodium acetate (denoted in figure): a ∆pfkA (JW3887) and b WH04. OD600 of cultures grown 
solely with 10 g/L of glucose are also included (closed circles). c Maximal growth rate of WT, 
JW3887, and WH04 in cultures supplemented with 6 g/L of sodium acetate during early 
exponential phase (black bar). Control cultivations (no acetate; white bar) were supplemented 
with 6 g/L of sodium chloride to normalize for ion effects. d 
13
C tracing in cultivations fed 
10 g/L of unlabeled glucose and 6 g/L of fully labeled 
13
C2-acetate. Acetate contribution (
13
C 
fraction) in proteinogenic amino acids are shown for the three strains. (n = 2). 
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5.2.3 Dynamic labeling pattern for sugar phosphates in ΔpfkA mutants 
We grew WT and the ΔpfkA mutants (WH04 and JW3887) with unlabeled glucose into 
the mid-exponential growth phase, and then we added uniformly 
13
C6-labeled glucose into the 
cultures. The resulting kinetics of 
13
C-labeling incorporation in key metabolites were examined. 
The WT demonstrated very fast metabolite turnover such that most metabolites’ labeling reached 
isotopic steady state in 15 seconds (Fig. 5.4A and Supporting Fig. S5.2). This observation is 
consistent with the rapid EMPP turnover rates previously reported (Nöh et al. 2007). In contrast, 
WH04 had lower rates of labeling incorporation, in which G6P and 6PG were labeled slower 
than their downstream metabolites (3PG and PEP) (Fig. 5.4B, Supporting Fig. S5.3). Similarly, 
the 
13
C-pulse experiment for JW3887 also revealed that 3PG and R5P reached isotopic steady 
state more quickly than their higher pathway metabolites (G6P and 6PG), revealing unusual 
labeling for both EMPP and OPPP (Supporting Fig. S5.4). 
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Figure 5.4 Dynamics labeling of central metabolites. 
Dynamics labeling of central metabolites. Labeling dynamics in selected metabolites postpulse 
of
13
C6-glucose into a Wild Type and b WH04. c Relative metabolite peak ratio of central 
metabolites in WT and ED mutant strains. The glycolysis key node (3PG) is used as the base of 
comparison. d Ratio of WT pool size to mutant pool size for G6P, 6PG, and MAL. The 
metabolite pools in two mutants, ∆pfkA (JW3887) and WH04, were measured via isotopomer 
ratio analysis. Asterisk 6PG measurement for WT was below detection 
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The unsequential 
13
C labeling patterns for glycolysis intermediates in ΔpfkA mutants 
could be explained by metabolite channeling (Fig. 5.5A): intermediates in metabolic pathways 
are passed from enzyme to enzyme without equilibration within the cellular medium (Williams 
et al. 2011). For example, a large unlabeled metabolite pool formed outside of the ‘channel’ 
could dilute the labeled metabolite concentration, resulting in a slow labeling incorporation of 
the bulk metabolite, as measured by LC-MS methods. The downstream metabolites, however, 
retain their fast rates with their production primarily from the metabolite pool within the 
‘channel’. In a previous study, in vivo evidence discovered that EMPP intermediates are mainly 
concentrated within the ‘channel’ with minimal mixing with the cytoplasmic pool (Shearer et al. 
2005). In vitro studies also suggest that the OPPP metabolites (e.g., 6PG) are highly channeled 
(Debnam et al. 1997; Malaisse et al. 2004). In this study, disruption of EMPP channel by the 
knockout of pfkA caused a bottleneck in the conversion of F6P to FBP, which likely allowed 
hexose6P metabolites to accumulate within the cytosol. LC-MS peak abundances and isotopomer 
ratio analysis (Fig. 4C and 4D) further confirmed that ∆pfkA (JW3887) and WH04 had larger 
G6P and 6PG pool sizes than those in the WT. During 
13
C-pulse experiments, the unlabeled G6P 
and 6PG amassed in the cytosol could significantly slow the measured labeling of bulk 
hexose6P, causing 
13
C to appear more gradually than in their downstream metabolites (3PG and 
PEP). Although there could be other reasons for the observed labeling patterns in ∆pfkA mutants, 
such as activation of unknown pathways, unknown influence of various side reactions, or the 
effect of cell subpopulations, channeling is one logical explanation which would have a great 
impact on the field. 
5.2.4  Fluxome response to changes in glycolytic pathway utilization 
Flux balance analysis (FBA) was used to predict growth and flux distribution under 
different glycolytic pathways and carbon substrates. Using the measured glycolytic flux ratios, 
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substrate utilization, and acetate production as constraints, we performed FBA simulations on the 
mutant strains using maximal biomass growth as the objective function (Fig. 5.6a, b). FBA-
predicted growth rate of WH04 agreed with the experimentally measured the glucose-based 
growth rate, while xylose and acetate co-utilization models show certain discrepancies. The 
measured growth rates of JW3887 were generally below the growth rates predicted by FBA 
(Fig.5. 6c). The knockout of pfkA may have unknown effects that cause a suboptimal metabolism 
for biomass synthesis. Unlike the WT strain, FBA predicted that ΔpfkA mutant and WH04 
upregulated the glyoxylate shunt and maintained low activity of anaplerotic pathways for glucose 
metabolism (Fig. 5.6a). Compared to WT, the absolute fluxes of energy production (ATP, 
NADH, and NADPH) rate in mutants were reduced (Fig. 5.6b). FBA improved our overview of 
the central metabolic responses to our glycolysis flux reorganization. 
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Figure 5.5 FBA of ΔpfkA (JW3887) and WH04. 
The FBA was constrained by the 
13
C-flux ratio and optimized for biomass accumulation. a Heat 
Map of the difference (Fluxmutant-FluxWT) in the optimal fluxes (normalized to total carbon 
uptake rate, which was set to one) between mutant strains (ΔpfkA-JW3887 and WH04) and WT 
(green showed increased relative flux compared to wild type, red showed decreased relative flux 
compared to wild type). b Absolute total productions of ATP, NADH, and NADPH. c Simulated 
and measured growth rates of the different strains and growth conditions. The wild-type strain 
glucose uptake rate was assumed to be 8.5 mmol/h/g DCW 
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5.3 Discussion 
Glycolytic pathways hold considerable control over carbon utilization and biosynthetic 
efficiency. The knowledge of their regulation is crucial for designing optimal microbial 
production strains. For example, the desire to use cheap cellulosic feedstock has prompted 
metabolic engineers to develop microbial hosts that utilize both 6- and 5-carbon sugars, 
simultaneously (Kim et al. 2010; Nieves et al. 2015). However, carbon catabolite repression 
(CCR) prevents the simultaneous consumption of other carbon sources. CCR is believed to act in 
E. coli by preferentially directing resources to consume glucose more efficiently by regulating its 
sugar transporters and carbon degradation pathways (Gorke and Stulke 2008).  Approaches such 
as adaptive evolution and overexpression of xylose transport and catabolic genes have been 
tested to minimize CCR (Kim et al. 2010). The knockout of phosphoenolpyruvate-dependent 
glucose phosphotransferase system (PTS, the primary transport system for glucose) has also been 
shown to be an effective way to enable glucose and xylose co-utilization (Chiang et al. 2013; 
Jung et al. 2015; Lu et al. 2016; Su et al. 2015), but has a negative effect on glucose uptake and 
growth rates.  In this study, ΔpfkA mutants also showed no CCR and employed xylose co-
consumption to increase its growth rate. ΔpfkA caused an increased pool size of G6P that may 
have inhibited PTS and decreased biomass accumulation (Chassagnole et al. 2002; Morita et al. 
2003).  
Gluconeogenesis is usually inactive under high glucose concentrations as it is regulated 
by phosphofructokinase and pyruvate kinase. The lack of EMPP flux could facilitate 
gluconeogenesis for utilization of non-sugar based substrates. This is seen in Rhodococcus 
opacus, which lacks pfk activity and shows simultaneous gluconeogenesis and EDP for sugar and 
phenol co-utilization (Hollinshead et al. 2016). In this study, ΔpfkA mutants actively utilized 
acetate from the glucose medium. This observation is encouraging since acetate is a notorious 
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inhibitor in E. coli cultivation, because acetate can freely diffuse through the cell membrane and 
disrupt the intracellular pH (Ding et al. 2015; Repaske and Adler 1981; Xiao et al. 2013). 
13
C-
labeling analysis of Asp and Glu revealed that both JW3887 and WH04 actively employed the 
TCA cycle to degrade 
13
C-acetate in the presence of glucose. However, increased EDP flux in 
WH04 repressed the gluconeogenesis activity since EDP overexpression drives high flux 
towards the lower portion of the EMPP.  
Despite being more thermodynamically favorable and requiring ~5-fold less enzymatic 
protein (Flamholz et al. 2013), the E. coli mutants grew slower than WT after overexpression of 
EDP genes. One reason could be the lower ATP yield of EDP as compared to EMPP (this 
explanation is questionable since respiration remains the main ATP production route in all 
aerobic cultures via our FBA simulations). The other explanation is metabolite channeling. The 
intracellular environment contains high amounts of macromolecules (30-60% of cell volume) 
creating a crowding effect within the cell that can reduce metabolite diffusion, thus channeling is 
an important mechanism for in vivo enzyme reactions (Zhang 2011). Channeling can be naturally 
accomplished in the cell via electrostatic interactions, intramolecular tunnels, and small spatial 
distances between enzymes (Wheeldon et al. 2016). In eukaryotic cells, channeling is present for 
the TCA cycle and other pathways, as eukaryotes have organized their pathways within 
organelles (Debnam et al. 1997; Malaisse et al. 2004). Pathways in E. coli have also been found 
to demonstrate forms of channeling, such as for fatty acid type II synthesis pathway (Janßen and 
Steinbüchel 2014; Mathews et al. 2013). As shown in this study and previous studies (Noor et al. 
2014), E. coli EMPP channeling would significantly improve reaction thermodynamics and 
overcome kinetic obstacles. Thereby, it could be an important factor in WT and WH03 
preference for EMPP rather than the EDP route.  
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If labeled G6P was being channeled in our experiments, then it must be channeled from its 
conversion of glucose to G6P. In E. coli cells, this primarily is the job of the glucose transport 
system, PTS, which uses PEP to uptake glucose and convert it to G6P. Using 1-
13
C glucose as 
the isotopic tracer, we estimated the flux redistribution after the knockout of ptsG using WUFlux 
(
13
C-MFA software)(He L et al. 2016). In Table 6.1, the flux distribution between the three 
glycolytic pathways show that the knockout of ptsG, effectively disrupting the PTS transport 
system, had a significant reduction in the flux through EMPP, a 60% increase of OPPP flux, and 
a small flux through EDP. Flores et al., 2002 similarly conducted flux analysis on ΔptsG to near 
identical flux results, while finding that despite the reduction in flux the knockout increased the 
enzyme levels of EMPP enzymes(Flores et al. 2002).  The small flux through EDP is too small to 
firmly state that the disruption of the channel also allows EDP to be a more competitive pathway. 
Therefore we introduced our plasmid pEDE (also denoted pEDW) into both the WT (BW25113) 
and ΔptsG. The resulting flux redistributions show much higher EDP flux enhancement in the 
strain containing an inactive PTS system as compared to active PTS transport. This observation 
is consistent with our hypothesis that the PTS system may play a part in metabolite channeling 
within EMPP.  
Table 5.2 Ratio of fluxes through glycolytic pathways in E. coli strains as determined by 
WUFlux. 
 
The channeling process is difficult to study noninvasively, particularly in the central 
metabolism. In an early study by the Kohl group, E. coli was engineered so that the mutants 
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could uptake both 
14
C-glucose and unlabeled sugar phosphates (Shearer et al. 2005). The authors 
found that the presence of unlabeled FBP in the culture medium did not dilute 
14
C EMPP 
intermediates or 
14
CO2, indicating a high degree of EMPP channeling. Debham et al., 1997 
isolated enzymes from the oxidative pentose phosphate pathway; they found the rate of 
14
C-
glucose to 
14
CO2 was not affected by providing external G6P or 6PG. Other pathways have also 
been investigated. Vélot, 2000 mutated citrate synthase and malate dehydrogenase in 
Saccharomyces cerevisiae to test the interactions of two enzymes, and found that while the 
mutations had little effect on their individual kinetic efficiencies it still caused a deficiency in the 
TCA cycle. In the present study, we performed 
13
C-pulse experiments to measure the labeling 
dynamics in WT and the ΔpfkA mutants (Supporting Fig. S5.2-S5.4). Our results supported the 
hypothesis that metabolites are not equilibrated in the cytoplasm (Fig. 5.6A & 6B). In this study, 
ΔpfkA mutants had slower metabolite transfer rates, and accumulated the upstream hexose6Ps 
outside of the channel. The resulting presence of two pools of the same metabolite allowed 
13
C-
pulse experiments to detect unsequential metabolite labeling through the EMPP.  
 
Figure 5.6 Schemes of hypothesized channeling and its influence on catabolite repression. 
101 
 
An enzymatic pathway of sequential metabolites W, X, Y, and Z forms a 
channel. Delta represents the presence of a bottleneck that limits flux through the channel. a In a 
fully channeled network, most substrates exist within the channel with few substrates existing in 
cytosol. The pulse of 
13
C (asterisk) into the channeled pathway results in sequential and fast 
labeling of metabolites W, X, Y, and Z. b In a fractured channel, a disturbance in an enzyme 
(X→Y) causes accumulation of X in the cytosol, which is metabolically less active. After the 
pulse of 
13
C (asterisk), the labeling of bulk X* will be diluted by unlabeled X
o
 in the cytosol 
during LC–MS analysis. The downstream metabolites Y and Z may show faster 13C-labeling if 
their unlabeled pools in cytosol are small. In this case, the pulse of 
13
C and measurement of 
metabolite labeling dynamics can capture the features of channeling. c Substrate channeling can 
be another factor leading to CCR. The presence of channeling favors fast W conversion through 
the channeled pathway, while diffusion of cytosol metabolite (X) from secondary substrate (U) 
into channeled pathway becomes limited. d Catabolite repression is reduced if the channeled 
pathway flux is downregulated, allowing for cytosol X to diffuse into the channeled pathway 
 
Channeling may have several implications on our understanding of cell physiology. First, 
metabolite channeling avoids diffusion limitations and thus significantly improves bioconversion 
efficiency (Wheeldon et al. 2016).  Channeling would explain the robustness of natively evolved 
pathways for biosynthesis, encouraging synthetic biologists to replicate channeling as a strategy 
to improve heterologous pathway efficiency (e.g., co-localization/compartmentalization of 
overexpressed enzymes) (Sarria et al. 2014). Second, it necessitates that we rethink the in vivo 
Gibbs free energy or kinetics typically reported in studies, since the global metabolite pool 
measurement does not reflect the local substrate concentrations (The notion of ‘one perfectly 
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mixed solution’ may be a poor reflection of the cell ‘in vivo’). This presents complications with 
metabolic modeling. Third, metabolite channeling could affect steady-state 
13
C-Metabolic Flux 
Analysis, because channeling may prevent the carbon randomization during conversion of a 
symmetric metabolite or introduce bypass routes for 
13
C labeling (Williams et al. 2011). Finally, 
we hypothesize that channeling could be another factor behind CCR. At high growth rates, the 
EMPP is capable of reaching fast glucose catabolic rates such that metabolites derived from 
other substrates (e.g., xylose) cannot sufficiently diffuse into the EMPP channel (i.e., glucose 
catabolite repression). During slow growth conditions, glucose catabolic flux decreases. This 
favors diffusion of metabolites from cytosol into the EMPP channel and encourage the co-
utilization of the secondary substrate (Fig. 5C & 5D). In reality,  inhibition of EMPP flux (e.g., 
removal of glucose transporter ΔptsG or glucose-limiting cultures) allows E. coli to co-
metabolize glycerol with glucose (Yao et al. 2016).  
5.4 Conclusion and Future Work 
 We’ve re-wired E. coli’s central metabolic network through a pfkA knockout and EDP 
overexpression. The altered strains alleviated glucose catabolite repression, and could be 
beneficial in biosynthesis from renewable cellulosic hydrolysates. Physiological analyses of 
different glycolytic strategy clearly revealed that despite the theoretical prediction that EDP is a 
preferred glycolysis pathway based on both thermodynamics and the cost of enzymatic protein, 
the cell prefers EMPP for optimal growth. The results of 
13
C-pulse experiment revealed a form of 
EMPP channeling that, if proven, could significantly affect our understanding of reaction 
thermodynamics, flux analysis, and synthetic biology applications.   
Steady state 
13
C-MFA relies heavily on metabolite labeling inferred from measured 
amino acid labeling distributions, but if reactions are channeled and bypass amino acid 
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production, this could lead to misleading labeling distributions.  Proving the hypothesis of 
metabolite channeling is important as it would have a vast impact on Gibbs free energy 
estimations, metabolic modeling, metabolic engineering, and genome-to-phenome mapping. 
However, proving metabolite channeling is also very challenging as most methods are indirect 
and have other possible explanations. Dynamic labeling experiments are one method that has 
provided much evidence, but most have been completed on engineered strains which remained 
unclear on how that shifts the cells’ behavior and unclear on how the kinetics of side reactions 
effects the labeling. In addition, the quenching and extraction necessary for dynamic labeling 
leaves possible problems with trace extracellular metabolite interference, effects of stressed 
conditions (e.g., cold shock), and culture heterogeneity. The best plan is to combine dynamic 
labeling studies with more physical evidence (e.g., of protein interactions) to further our 
understanding of the mechanism employed for channeling. Synthetic biologists have already 
attempted to recreate metabolite channeling through engineering enzyme co-localizations via  
direct protein fusions, protein surfaces’ interactions, and protein or DNA scaffolds(Baek et al. 
2013; Dueber et al. 2009; Lee et al. 2013; Moon et al. 2010; Sachdeva et al. 2014; Wang and Yu 
2012). However, in some of these cases, the introduced inclusions bodies have been found to 
negatively impact cell division(Lee et al. 2013).  
5.5 Methods 
5.5.1 Chemicals 
Glucose, [1-
13
C] glucose, [U-
13
C] glucose, [U-
13
C] acetate, and all other chemicals unless 
otherwise stated were purchased from Sigma Aldrich (St. Louis, MO). Q5 High Fidelity 2X 
Master Mix was obtained from New England Biolabs (Ipswich, MA), all other enzymes were 
purchased through Thermo Scientific (Waltham, MA).  
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5.5.2 Construction of strains and plasmids 
All plasmids were developed from a BglBrick expression vector,  pBbE5c-YFP, which contains 
a ColE1 origin of replication, chloramphenicol resistance and LacUV5 promoter (Lee et al. 
2011). The genes, phosphogluconate dehydratase (edd) and 2-dehydro-3-
deoxyphosphogluconate aldolase (eda) were PCR- amplified from genomic DNA of E. coli K-12 
MG1655.  The plasmid pEDW was assembled from the PCR-amplfied genomic region from edd 
to eda into pBbE5c backbone via Gibson assembly.  Primers used for plasmid construction are 
the following:  
eddeda01_fwd: CTTTTAAGAAGGAGATATACATATGAATCCACAATTGTTACGCG  
eddeda01_rev: CGAGTTTGGATCCTTACAGCTTAGCGCCTTCTACAGC 
vecbac01_fwd: GGCGCTAAGCTGTAAGGATCCAAACTCGAGTAAGGATCTCC  
vecbac01_rev: 
CGCGTAACAATTGTGGATTCATATGTATATCTCCTTCTTAAAAGATCTTTTGAATTC  
Table 1 lists the resulting mutant strains, their JBEI ICE registry numbers, and growth rates. All 
strains generated at JBEI are available thought the JBEI Registry (https://acs-registry.jbei.org; 
(Ham et al. 2012)). The plasmid was first transformed into DH10B for plasmid propagation, and 
then verified by sequencing completed by Quintara (San Francisco, CA). After verification for 
no mutations, the plasmid was transformed into Keio collection strains, BW25113 (WT) and the 
∆pfkA mutant (JW3887) (Baba et al. 2006), obtained from the Yale E. coli Genetic Stock Center 
(New Haven, CT).  
5.5.3 Media Composition and Growth Conditions 
Seed cultures were grown in LB for ~12 hours, then inoculated (2% v/v) in M9 minimal medium 
overnight. Strains were then inoculated in fresh M9 minimal medium (~2% v/v). The M9 
medium (pH=7~7.5) consisted of 11 g/L of 5X M9 salts (Sigma Aldrich, St. Louis, MO), 2mM 
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MgSO4●7H2O, 0.1mM CaCl2●2H2O, 1 mg/L of Thiamine HCl, 3 mg/L of FeSO4●7H2O, and 
trace minerals. Initial sugar concentrations were 10 g/L of glucose and 6 g/L of xylose. For 
mutant cultures, 30 mg/L chloramphenicol and 10 mg/L kanamycin were supplied as needed. 50 
µM Isopropyl β-D-1-thiogalactopyranoside (IPTG) was used to induce plasmid borne genes at 
early exponential growth phase. To study acetate co-utilization, 6g/L sodium acetate (or 6g/L 
NaCl served as a control) were added at early phase of mutant cultures (OD600~0.2, pH~7.5) with 
the IPTG induction. All cultivations were aerobic and conducted in 5 mL cultures in test tubes on 
a rotary shaker at 250 rpm at 37 
O
C. For labeling experiments, unlabeled glucose was replaced 
with 100% [1-
13
C] glucose or 100% [U-
13
C] glucose, and unlabeled acetate was replaced with 
[U-
13
C] acetate. 
5.5.4 13C-Pulse Experiments 
Strains were grown in approximately 70 mL cultures in 250 mL Erlenmeyer flasks on a rotary 
shaker at 250 rpm with 2g/L unlabeled glucose M9 media. In all 
13
C-pulse experiments, cultures 
in exponential growth phase (pH=6~7) were pulsed with 5 mL ~60 g/L 
13
C6-glucose stock 
solution. To measure the 
13
C- incorporation into glycolysis metabolites over time, cultures were 
harvested at different time points (from 15s to 3 minutes). The harvested samples were quenched 
using the procedure of Fast-Cooling (Fu et al. 2015). Specifically, ~10mL culture was poured 
into a 50mL falcon tube containing 2mL ice-cold M9 medium (no carbon source) and the tube 
was immediately immersed in liquid N2. To facilitate heat transfer and avoid ice formation in the 
sample solution during the liquid N2 bath, the sample solutions were manually agitated using a 
digital thermometer. The sample solution could be cooled to 0 
o
C in 10 seconds. The ice-cold 
samples were centrifuged at 0 °C for 3 minutes and the pellets were stored at -80 °C until 
metabolite extraction.  
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5.5.5 Sugar Measurement 
Supernatant samples were taken in parallel experiments separate from cultures used for 
optical density measurement to reduce the loss of volume. At each time point, at least 150 µL 
of culture was extracted, centrifuged to remove cell biomass, and stored at -20 
o
C. Samples 
were diluted by 2X and then filtered through 0.22 μm centrifugal filters. Samples were run on 
an Agilent Technologies 1200 series HPLC equipped with an Aminex H column, the 
concentrations were estimated based on standard curves(Rodriguez et al. 2016).  
5.5.6 Amino acid extraction and GC-MS analysis 
Amino acid extraction and GC-MS analysis were performed as described previously (You et al. 
2012). Briefly, cell pellets from 5 mL cultures taken during the exponential phase were washed 
with 0.9% (w/v) of NaCl solution, and then hydrolyzed in 6M HCl at 100 
o
C. The resulting 
amino acids were derivatized by N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide prior to 
GC-MS analysis. For isotopic tracing, we used the fragments [M-15]
+
 or [M-57]
+ 
(containing the 
entire amino acid backbone) and [M-159]
+
 or [M-85] (containing the amino acid backbone after 
loss of its first carbon). The natural isotopic abundance of derivatized amino acids was corrected 
using a reported algorithm (Wahl et al. 2004a).  The mass isotopomer distributions of alanine 
and serine for the strains used are given in Supporting Table S5.1. 
1-
13
C glucose was used to measure in vivo glucose catabolism: the OPPP cleaves the 
labeled carbon as CO2; the EDP produces a 1
st
 carbon labeled pyruvate; while EMPP results in 
the labeled carbon present in the third position of pyruvate(Romano and Conway 1996). GC-MS 
analysis of alanine (synthesized from pyruvate) can reveal this positional labeling as further 
described previously (Borodina et al. 2005; Hollinshead et al. 2016; Klingner et al. 2015). 
Equations 1-3 were solved for estimation of the flux ratios between the three pathways (without 
considering metabolite channeling effect): 
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 𝐴𝑙𝑎100 =
𝑣𝐸𝐷𝑃
2𝑣𝐸𝐷𝑃 + 2𝑣𝐸𝑀𝑃𝑃 +
5
3 𝑣𝑂𝑃𝑃𝑃
 
(1) 
 
𝐴𝑙𝑎000 =
5
3 𝑣𝑂𝑃𝑃𝑃 + 𝑣𝐸𝐷𝑃 + 𝑣𝐸𝑀𝑃𝑃
2𝑣𝐸𝐷𝑃 + 2𝑣𝐸𝑀𝑃𝑃 +
5
3 𝑣𝑂𝑃𝑃𝑃
 (2) 
 𝐴𝑙𝑎001 =
𝑣𝐸𝑀𝑃𝑃
2𝑣𝐸𝐷𝑃 + 2𝑣𝐸𝑀𝑃𝑃 +
5
3 𝑣𝑂𝑃𝑃𝑃
 
(3) 
where vEDP, vEMPP, and vOPPP are the estimated fluxes for the EDP, EMPP, and OPPP, 
respectively. Alaxxx are the fractions of the isotopomer determined by fragmentation data, with 1 
denoting a 
13
Carbon isotope.  For example, Ala100 is the fraction of alanine labeled at carbon 
position 1, a unique isotopomer produced by the EDP. The calculated flux ratios are estimations, 
which assume the reactions are irreversible. 
5.5.7 Metabolite Extraction and LC-MS Analysis 
After quenching, the cell pellet was suspended in 1 mL of cooled 7:3 methanol:chloroform 
mixture. These samples were then placed on a rotary shaker at 250 rpm, overnight at 4 
o
C. The 
methanol layer was separated with the addition of 500 µL of water, then filtered through an 
Amicon Ultra centrifuge filter (3,000Da; EMD Millipore, Billerica, MA), lyophilized (-50 
o
C) 
and reconstituted in 100 µL of acetonitrile-water (6:4, v/v). The samples were then analyzed via 
liquid chromatography-mass spectrometry (LC-MS) using a SeQuant Zic-pHILIC column (EMD 
Millipore, Billerica, MA, USA) in an Agilent Technologies 1200 Series HPLC system. The 
mobile phase was composed of 15 mM ammonium carbonate (Sigma-Aldrich, St. Louis, MO, 
USA) in water (solvent A) and 15 mM ammonium carbonate in 75% acetonitrile and 25% water 
(solvent B). A flow rate of 0.2 ml/min was used, unless stated otherwise. Metabolites were 
separated via gradient elution under the following conditions: 100% B (0 min), 82% B (4.4 min), 
72% B (7.7 min), 60% B (9.7 min), 100% B (10.2 min), 100% B (12.5 min), 100% B (13 min, 
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0.4 mL/min), and 100% B (18.5 min, 0.4 ml/min). The HPLC system was coupled to an Agilent 
Technologies 6210 series time-of-flight mass spectrometer (for LC-TOF MS) via a MassHunter 
workstation (Agilent Technologies, USA). A split ratio of 1:4 was used throughout. Drying and 
nebulizing gases were set to 10 L/min and 25 lb/in
2
, respectively, and a drying-gas temperature 
of 300°C was used throughout. Electrospray ionization (ESI) was conducted in the negative ion 
mode and a capillary voltage of 3,500 V was utilized. The acquisition range was from 70-1000 
m/z, and the acquisition rate was 0.86 spectra/s. Metabolite mass isotopomer distribution was 
determined based on the ratio of the integrated peak area of the chosen isotopomer to the sum of 
all the integrated peak areas of the possible isotopomers for the given metabolite.  
5.5.8 Estimation of Pool Size via Isotope-ratio Approach 
 The relative pool size of key metabolites (G6P, 6PG, and MAL) were measured via an 
isotope-based ratio approach, as modified from (Bennett et al. 2008). Wild type (BW25113) was 
cultivated in 5 g/L of 
13C6-glucose and 1 g/L of fully labeled 
13
C-sodium bicarbonate, which 
generated 
13
C-metabolites as internal standards. The fully labeled WT biomass and the unlabeled 
mutant cultures were quenched using liquid N2 as described earlier, then mixed together at 1:1 
volume ratio for metabolite extraction. The ratio of WT metabolite pool size (labeled peak area) 
to the mutant strains metabolite pool size (unlabeled peak area) was determined using LC-MS, 
which provided a qualitative comparison of metabolite pool sizes between WT and mutants. 
5.5.9 Flux Balance Analysis Constrained by Measured Flux Ratios 
The E. coli Genome Scale Model iJO1366 (2251 metabolic reactions) was adapted for metabolic 
modeling of mutants under the different growth conditions (Orth et al. 2011). Flux Balance 
Analysis (FBA) chose objective function: 
Maximize µ 
Subject to: 𝐒 ∙ 𝐯 = 0 
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𝐥𝐛 ≤ 𝐯 ≤ 𝐮𝐛 
where S represents the stoichiometric matrix, v represents the matrix of reaction rates (fluxes), 
while matrices lb and ub are the lower and upper bounds, respectively. Glucose, xylose, and 
acetate uptake rates were fixed to measured values. Flux ratios determined by 
13
C-analysis was 
used to constrain fluxes through EMPP, EDP and OPPP (Fig. 1). As the activities of pfkA and 
pfkB were lumped in iJO1366, the PFK reaction was not constrained. All generated fluxes were 
normalized to total substrate uptake rate.  
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5.6 Supplemental Information for Chapter 5 
Table S5.1. Mass Isotopomer Distribution of Alanine and Serine 
 BW25113 WH03 JW3887 WH04 
m-57 Alanine 
m+0 0.53 0.51 0.67 0.54 
m+1 0.46 0.49 0.33 0.46 
m+2 0.01 0.00 0.00 0.00 
m+3 0.00 0.00 0.00 0.00 
m-85     
m+0 0.54 0.62 0.74 0.95 
m+1 0.46 0.38 0.27 0.05 
m+2 0.00 0.00 0.00 0.00 
m-57 Serine 
m+0 0.56 0.59 0.71 0.87 
m+1 0.44 0.42 0.29 0.13 
m+2 0.00 0.00 0.00 0.00 
m+3 0.00 0.00 0.00 0.00 
m-159     
m+0 0.56 0.59 0.71 0.93 
m+1 0.44 0.41 0.28 0.07 
m+2 0.00 0.0 0.00 0.00 
Note: All standard deviations are <0.02.  
  
111 
 
 
Figure S5.1. Glucose Consumption in (A) JW3887-∆pfkA and (B) WH04 
 
 
 
Figure S5.2. Dynamics of 
13
C-labeling Pulse Experiment for WT (BW25113).   
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Figure S5.3. Dynamics of 
13
C-labeling Pulse Experiment for WH04.  
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Figure S5.4. 
13
C-Isotopic Incorporation kinetics in JW3887-∆pfkA glucose culture taken 
immediately after 
13
C6-Glucose pulse (final labeled glucose concetrantion ~ 4 g/L). *Note  
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6 Chapter Six: Conclusion and Future Directions 
6.1 Conclusion 
In metabolic engineering, we use the design-build-test-learn cycle in which we first design 
an engineering strategy, build our engineered or adapted strains, and then test their performance. 
The learn stage should then incorporate systems biology approaches to build better 
understanding and awareness of any underlying barriers or bottlenecks to achieving our desired 
goals. With the advancement in molecular cloning techniques and automation, researchers and 
companies can now quickly design, build, and test strains in large quantities and at record speeds. 
Systems biology approaches, specifically fluxomics, must now be adapted to provide 
information for multiple strains with less turnover time and lower costs. 
 In this thesis, we were motivated by this need to develop the methodology discussed in 
chapter 2 that included a high-throughput qualitative protocol.  The method integrates parallel 
13
C-isotopic experiments to build larger views of the flux topology in strains in under ~3 days 
(growth of strain not considered in this estimate). The efficacy of this 
13
C-fingerprinting method 
was successful in providing several novel insights in Rhodococcus opacus PD630, a promising 
phenol-tolerant host for biodiesel production. Most importantly, the results strongly suggested an 
active gluconeogenesis and Entner-doudoroff pathway (EDP) as a metabolic strategy supporting 
the strain’s lack of carbon catabolite repression in phenol-glucose fed cultures.    
In certain cases, quantitative flux analysis is often necessary to fully identify the influential 
factors in a systems and comparative manner as demonstrated in Chapter 4.  
13
C-Metabolic Flux 
Analysis of Synechoccocus 2973 revealed many rational metabolic engineering strategies for 
developing Synechocystis 6803 to become a more efficient autotrophic and heterotrophic 
microbial cell factory. However, unknown biological constraints (incompatible heterologous 
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enzymes, hidden regulation, or etc.) prevented our assay from detecting the activity of the 
introduced EDP.   
We’ve also explored increasing the EDP activity in E. coli for better carbon co-utilization in 
Chapter 5. While it did relieve glucose catabolite repression on xylose, it failed to improve 
glucose-acetate cultivations. Though, the down regulation of EMPP through the deletion of pfkA 
was sufficient to relieve the glucose-xylose regulation as well as glucose-acetate regulation. In 
addition, the 
13
C labeling dynamics within the ΔpfkA mutants generated unusual labeling 
distributions with early metabolites (G6P and 6PG) labeled slower than their subsequent 
metabolites.  While there may be other explanations behind the non-sequential labeling, we 
hypothesize that this could be due to metabolite channeling (due to large metabolically inactive 
pools of G6P & 6PG).  
6.2 Future Directions 
In this thesis, we have optimized 
13
C-metabolism analysis tools, characterized promising 
non-model organisms, and translated our findings into new engineering strategies for model 
organisms that ultimately discovered possible hidden constraints in modifying central pathways.  
This work is a move into discovering new strategies to improve bioprocess feasibilitie. For 
example, this work demonstrated the importance of searching and developing new nonmodel 
species.  
For the future of bio-based productions, the field needs to incorporate economics and life 
cycle analysis to clearly demonstrate that the particular scientific path has a road to success. For 
example, new proposed projects should evaluate the potential theoretical yields that can be 
accomplished, the potential profit margin of the process, and the energy yield. The biotechnology 
field advertises itself as an environmentally-friendlier and energy-efficient alternative but most 
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studies failed to evaluate using life cycle analysis the veracity of that claim.  Moving forward, a 
review of the current state of bio-based productions and the improvements needed to reach a 
break-even point for success would help to rationally direct the field to worthwhile projects. 
Finally, the use of 
13
C-metabolism analysis in examining metabolic shifts on fermentation would 
be an interesting direction. As traditional chemical engineers greatly optimized synthetic reaction 
engineering by improving their understanding of the mixing and state of the reactions within 
reactors, bioprocess engineers must also investigate the hindrances experienced at production 
scales to advance the scale-up process.  Though the dynamic flux analysis of heterogeneous 
bioreactor cultures makes this avenue an expensive venture, I believe this tool with careful 
planning could illustrate cell responses in these large-size reactors. The future is still bright for 
bio-based productions with the right products, robust microbial hosts, and cost-efficient process.   
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9 Appendix 2: Boosting D-lactate using sterilized anaerobic 
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10 Appendix 3:Mortierella isabellina growth and carbon 
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